[go: up one dir, main page]

WO2002059119A1 - Acylation of amino-isothiazoles using trialky-aluminium agents - Google Patents

Acylation of amino-isothiazoles using trialky-aluminium agents Download PDF

Info

Publication number
WO2002059119A1
WO2002059119A1 PCT/GB2002/000331 GB0200331W WO02059119A1 WO 2002059119 A1 WO2002059119 A1 WO 2002059119A1 GB 0200331 W GB0200331 W GB 0200331W WO 02059119 A1 WO02059119 A1 WO 02059119A1
Authority
WO
WIPO (PCT)
Prior art keywords
optionally substituted
alkyl
alkoxy
compound
hydrogen
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
PCT/GB2002/000331
Other languages
French (fr)
Inventor
Steven Fitzjohn
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Syngenta Ltd
Original Assignee
Syngenta Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Syngenta Ltd filed Critical Syngenta Ltd
Publication of WO2002059119A1 publication Critical patent/WO2002059119A1/en
Anticipated expiration legal-status Critical
Ceased legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D417/00Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/12Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07FACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F5/00Compounds containing elements of Groups 3 or 13 of the Periodic Table
    • C07F5/06Aluminium compounds
    • C07F5/061Aluminium compounds with C-aluminium linkage
    • C07F5/066Aluminium compounds with C-aluminium linkage compounds with Al linked to an element other than Al, C, H or halogen (this includes Al-cyanide linkage)

Definitions

  • This invention relates to a method for preparing an isothiazole derivative.
  • Certain compounds comprising an isothiazole ring system linked to a second heteroaryl ring system via an amide or analogous linkage, are known from WO-95/31448, WO-97/18198, WO-98/02424, WO-98/05670, WO-98/17630 and WO-00/06566. Further examples of such compounds are given in co-pending UK patent applications nos. 0002031.3, 0002035.4, 0002036.2 and 0002041.2. Some of the compounds have pesticidal (which includes fungicidal, insecticidal, acaricidal, molluscicidal and/or nematicidal) activity. Particular examples of such compounds are those of the general formula (I):
  • A is optionally substituted Q. 6 alkylene, optionally substituted C . 6 alkenylene, optionally substituted C 2 . 6 alkynylene, optionally substituted cycloalkylene, optionally substituted Q- 6 alkylenoxy, optionally substituted oxy(Q- 6 )alkylene, optionally substituted C ⁇ - 6 alkylenethio, optionally substituted thio(C 1 - 6 )alkylene, optionally substituted Ci- 6 alkylenamino, optionally substituted amino(C ⁇ - 6 )alkylene, optionally substituted [C ⁇ - 6 alkyleneoxy(C ⁇ - 6 )alkylene], optionally substituted [C ⁇ - 6 alkylenethio(C ⁇ - 6 )alkylene], optionally substituted [Q- 6 alkylenesulfinyl(Cj .
  • B is N, N-oxide or CR 8 ;
  • Z is O, S orNR 10 ;
  • R 1 is hydrogen, halogen, optionally substituted Q- 6 alkyl, optionally substituted C 2 - 6 alkenyl, optionally substituted C 2 - 6 alkynyl, optionally substituted - 6 alkoxy, optionally substituted Q- 6 alkylthio, optionally substituted C 3 - 7 cycloalkyl, cyano, nitro or SF 5 ;
  • R 2 is hydrogen, halogen, optionally substituted Q-6 alkyl, optionally substituted C 2 - 6 alkenyl, optionally substituted C 2 - 6 alkynyl, optionally substituted Ci- 6 alkoxy, optionally substituted d- ⁇ alkylthio, optionally substituted - 6 alkylsulfmyl, optionally substituted Q- 6 alkylsulfonyl, cyano, nitro, formyl, optionally substituted Ci-6 alkylcarbonyl, optionally substituted Q- 6 alkoxycarbonyl, SF 5 or R n
  • R 4 , R 5 and R 6 are, independently, hydrogen, halogen, optionally substituted Q- 6 alkyl, optionally substituted Q- 6 alkoxy, optionally substituted Q-6 alkylthio, optionally substituted Q- 6 alkylsulfinyl, optionally substituted Q- 6 alkylsulfonyl, cyano, nitro, optionally substituted Q- 6 alkylcarbonyl, optionally substituted Q- 6 alkoxycarbonyl or SF 5 ;
  • R 7 is hydrogen, halogen, cyano, optionally substituted Q- o alkyl, optionally substituted C 2 -2 0 alkenyl, optionally substituted C 2 - 20 alkynyl, optionally substituted C 3 - cycloalkyl, optionally substituted C 5 - 6 cycloalkenyl, formyl, optionally substituted Q- 20 alkoxycarbonyl, optionally substituted Q- o alkylcarbonyl, aminocarbonyl,
  • R 8 is hydrogen, halogen, nitro, cyano, optionally substituted Q-g alkyl, optionally substituted C 2 - 6 alkenyl, optionally substituted C 2 .
  • R 9 is hydrogen, cyano, nitro, optionally substituted Ci- 6 alkyl, optionally substituted C 3 - 7 cycloalkyl, optionally substituted (C 2 - 6 )alkenyl(Q- 6 )alkyl, optionally substituted (C 2 - 6 )alkynyl(Q- 6 )alkyl, optionally substituted phenyl, optionally substituted heteroaryl, optionally substituted Q- 6 alkylcarbonyl, optionally substituted Q-6 alkoxycarbonyl, optionally substituted Q- 6 alkylamino, optionally substituted di(Q- 6 )alkylamino, optionally substituted Q- 6 alkylcarbonylamino, optionally substituted Ci- 6 alkoxycarbonylamino, optionally substituted Q- 6 alkoxy, optionally substituted Ci- 6 alkylthio, optionally substituted Ci- 6 alkylsulfinyl, optionally substituted Q- 6 alkylsulfony
  • R 10 is hydrogen, cyano, optionally substituted Q- 8 alkyl, optionally substituted [C 2 - 6 alkenyl(C 1 - 6 )alkyl], optionally substituted [C 2 - 6 alkynyl(Q- 6 )alkyl], optionally substituted C 3 - 7 cycloalkyl, optionally substituted [C 3 - cycloalkyl(C ⁇ - 6 )alkyl], Q- 6 alkoxy(Q- 6 )alkyl, optionally substituted Q- 6 alkoxycarbonyl, optionally substituted Q- 6 alkylcarbonyl, optionally substituted Q- 6 alkylaminocarbonyl, optionally substituted di(Q- 6 )alkyl-uminocarbonyl, optionally substituted phenyl, optionally substituted heteroaryl, optionally substituted alkylsulfonyl or optionally substituted arylsulfonyl;
  • R 11 and R 18 are, independently, hydrogen, optionally substituted phenyl (Q_ 2 )alkyl or optionally substituted.Q-20 alkyl;
  • R 12 and R 19 are, independently, hydrogen, optionally substituted phenyl or optionally substituted Q- 6 alkyl;
  • R 13 and R 14 are, independently, optionally substituted Ci- 6 alkyl; or R 13 and R 14 together with the N atom to which they are attached form a five, six or seven-membered heterocyclic ring which may contain one or two further heteroatoms selected from O, N and S and which is optionally substituted by one or two independently selected Q-6 alkyl groups;
  • R 15 is hydrogen, optionally substituted Q- 20 alkyl, optionally substituted [C 2 - 2 o alkenyl(Q- 6 )alkyl], optionally substituted [C 2 -2 0 alkynyl(Q- 6 ) alkyl], optionally substituted C 3 .
  • R 16 and R 17 are, independently, hydrogen, optionally substituted Q- 20 alkyl, optionally substituted C 3 - 7 cycloalkyl, optionally substituted [C 2 - 20 alkenyl(Q- 6 )alkyl], optionally substituted [C 2 - 2 o alkynyl(Q- 6 )alkyl], optionally substituted Ci- 20 alkoxycarbonyl, optionally substituted phenoxycarbonyl, formyl, optionally substituted Q- 2 o alkylcarbonyl, optionally substituted Q- 2 o alkylsulfonyl or optionally substituted phenylsulfonyl.
  • Methods for preparing certain compounds of formula (I) are disclosed in WO-00/06566; they involve acylation of an amino-isothiazole (which provides the left-hand ring system) with an appropriate acid, acid chloride or acid anhydride to provide the right-hand ring system and an appropriate linking group.
  • the reaction is carried out in the presence of an alkoxide base such as sodium methoxide or potassium tertiary-butoxide.
  • a first aspect of the present invention provides an alternative method for the preparation of a compound of formula (I) which makes use of so-called "Weinreb" chemistry.
  • reaction avoids the use of strongly acidic or basic conditions, under which certain reagents can be susceptible to nucleophilic attack, ring opening and other undesired reactions.
  • the method of the present invention comprises reacting together an amino-isothiazole of the general formula (II):
  • This method can provide a ready means of preparing compounds of formula (I), in particular where the requisite reactant (IU) is base- or nucleophile-sensitive. It may be of particular use where the reactant (III) is a benzoxazole derivative (ie, B is nitrogen and Z is oxygen) such as a benzoxazole ester (ie, L is R 30 -O-), especially where the substituent R 7 is electron withdrawing.
  • the reactant (III) is a benzoxazole derivative (ie, B is nitrogen and Z is oxygen) such as a benzoxazole ester (ie, L is R 30 -O-), especially where the substituent R 7 is electron withdrawing.
  • Examples of compounds of formula (I), which may be produced using the method of the present invention, are disclosed in WO-00/06566 and in co-pending UK patent applications nos. 0002031.3, 0002035.4, 0002036.2 and 0002041.2. Some compounds of formula (I) have been found to be pesticidally (in particular insecticidally and/or fungicidally) active.
  • A is optionally substituted Ci- 6 alkylene, optionally substituted C 2 - 6 atkenylene, optionally substituted C 2 - 6 alkynylene, optionally substituted Q- 6 alkylenoxy, optionally substituted oxy(Ci- 6 )alkylene, optionally substituted Q- 6 alkylenethio, optionally substituted thio(Q- 6 )alkylene, optionally substituted Q- 6 alkylenamino, optionally substituted arnino-(Q- 6 )alkylene, optionally substituted [Q- 6 alkyleneoxy(Q- 6 )alkylene], optionally substituted [Q- 6 alkylenethio(Q- 6 )alkylene], optionally substituted [Ci- 6 alkylenesulfinyl(Q- 6 )alkylene], optionally substituted [Ci- 6 alkylenesulfony
  • R 3 is hydrogen, optionally substituted Q- 10 alkyl, optionally substituted [C 2 - 6 alkenyl(Ci- 6 )alkyl], optionally substituted [C 2 - 6 alkynyl(Ci- 6 )alkyl], optionally substituted C 3 - 7 cycloalkyl, optionally substituted Q- 10 alkylcarbonyl, optionally substituted C ⁇ o alkoxycarbonyl, formyl, optionally substituted Q-io alkylaminocarbonyl, optionally substituted di(Q- ⁇ o)alkylan ⁇ inocarbonyl, optionally substituted phenoxycarbonyl, optionally substituted Ci- 6 alkylthio, optionally substituted Q- 6 alkylsulfinyl, optionally substituted Q-e alkylsulfonyl, optionally substituted Q- 6 arylthio, optionally substituted Q- 6 arylsulfinyl, optionally substituted Q- 6 arylsulf
  • R 4 , R 5 and R 6 are, independently, hydrogen, halogen, optionally substituted Q- 6 alkyl, optionally substituted Q- 6 alkoxy, optionally substituted Ci- 6 alkylthio, optionally substituted Q- 6 alkylsulfinyl, optionally substituted Q- 6 alkylsulfonyl, cyano, nitro, optionally substituted Q- 6 alkylcarbonyl, optionally substituted Q- 6 alkoxycarbonyl or SF 5 ;
  • R 7 is hydrogen, halogen, cyano, optionally substituted Q. 2 o alkyl, optionally substituted C - 2 o alkenyl, optionally substituted C 2 - 20 alkynyl, optionally substituted C 3 - 7 cycloalkyl, optionally substituted C 5 - 6 cycloalkenyl, formyl, optionally substituted Q- 2 o alkoxycarbonyl, optionally substituted Q- 2 o alkylcarbonyl, aminocarbonyl, optionally substituted Q- 2 o alkylaminocarbonyl, optionally substituted di(Q- 2 o)alkylaminocarbonyl, optionally substituted aryloxycarbonyl, optionally substituted arylcarbonyl, optionally substituted arylaminocarbonyl, optionally substituted N-alkyl-N-arylaminocarbonyl, optionally substituted diarylaminocarbonyl, optionally substituted heteroaryloxycarbonyl, optionally substituted hetero
  • R 1 is hydrogen, halogen, optionally substituted Ci- 6 alkyl, optionally substituted C 2 - 6 alkenyl, optionally substituted C 2 - 6 alkynyl, optionally substituted Ci- 6 alkoxy, optionally substituted Ci-6 alkylthio, optionally substituted C 3 - 7 cycloalkyl, cyano, nitro or SF 5 ;
  • R and R together with the atoms to which they are attached may be joined to form a five, six or seven-membered saturated or unsaturated ring carbocylic or heterocyclic ring which may contain one or two heteroatoms selected from O, N or S and which may be optionally substituted by - 6 alkyl, Q- 6 haloalkyl or halogen;
  • R 9 is hydrogen, cyano, nitro, optionally substituted Q- 6 alkyl, optionally substituted C 3 - 7 cycloalkyl, optionally substituted (C 2 - 6 )alkenyl(Q- 6 )alkyl, optionally substituted (C 2 - 6 )alkynyl(Q- 6 )alkyl, optionally substituted phenyl, optionally substituted heteroaryl, optionally substituted Ci-6 alkylcarbonyl, optionally substituted Ci- 6 alkoxycarbonyl, optionally substituted Ci- 6 alkylamino, optionally substituted di(Q- 6 )alkylamino, optionally substituted Ci-6 alkylcarbonylamino, optionally substituted Q- 6 alkoxycarbonylamino, optionally substituted Ci-6 alkoxy, optionally substituted Ci-6 alkoxy, optionally substituted Ci-6 alkoxy, optionally substituted Ci-6 alkoxy, optionally substituted Ci-6 alkoxy, optionally substituted Ci-6 al
  • R 10 is hydrogen, cyano, optionally substituted Q- 8 alkyl, optionally substituted [C 2 - 6 alkenyl(Ci-6)alkylJ. optionally substituted [C 2 - 6 alkynyl(Q- 6 )alkyl], optionally substituted C 3 - 7 cycloalkyl, optionally substituted [C 3 - 7 cycloalkyl(Q- 6 )alkyl], Q- 6 alkoxy(Q- 6 )alkyl, optionally substituted Q- 6 alkoxycarbonyl, optionally substituted Ci- 6 alkylcarbonyl, optionally substituted Q- 6 alkylaminocarbonyl, optionally substituted di(Q-6)alkylaminocarbonyl, optionally substituted phenyl, optionally substituted heteroaryl, optionally substituted alkylsulfonyl or optionally substituted arylsulfonyl; R 8 is hydrogen, halogen, nitro, cyano, optionally substituted
  • alkyl optionally substituted C2- 6 alkenyl, optionally substituted - 6 alkynyl, optionally substituted C 3 . 7 cycloalkyl, optionally substituted Ci- 6 alkoxycarbonyl, optionally substituted Ci-6 alkylcarbonyl, optionally substituted Ci- 6 alkylaminocarbonyl, optionally substituted di(Ci- 6 )alkylaminocarbonyl, optionally substituted phenyl or optionally substituted heteroaryl;
  • R 13 and R 14 are, independently, optionally substituted Ci- 6 alkyl or R 13 and R 14 together with the N atom to which they are attached form a five, six or seven-membered heterocyclic ring which may contain one or two further heteroatoms selected from O, N or S and which may be optionally substituted by one or two Q- 6 alkyl groups;
  • R 16 and R 17 are, independently, hydrogen, optionally substituted Q- 2 o alkyl, optionally substituted C 3 - 7 cycloalkyl, optionally substituted [C2- 20 alkenyl(Q- 6 )alkyl].
  • R 18 and R 11 are, independently, hydrogen, optionally substituted phenyl (Q_ 2 )alkyl or optionally substituted Q- 2 o alkyl; and R 19 and R 12 are independently hydrogen, optionally substituted phenyl or optionally substituted Ci-6 alkyl.
  • R 26 and R 27 are, independently, hydrogen, Q- 8 alkyl, C 3 - cycloalkyl, C 2 - 6 alkenyl(Q- 6 )alkyl, C 2 - 6 alkynyl(Q- 6 )alkyl, C 2 - 6 haloalkyl, Q-6 alkoxy(Q- 6 )alkyl, Ci- 6 alkoxycarbonyl(Q- 6 )alkyl,
  • Each alkyl moiety is a straight or branched chain and is, for example, methyl, ethyl, n-propyl, ra-butyl, n-pentyl, n-hexyl, wo-propyl, n-butyl, -fee-butyl, wo-butyl, tert-butyl or neo-pentyl.
  • the optional substituents on an alkyl moiety include one or more of halogen, nitro, cyano, NCS-, C 3 - 7 cycloalkyl (itself optionally substituted with Ci- 6 alkyl or halogen), C 5 - cycloalkenyl (itself optionally substituted with Q- 6 alkyl or halogen), hydroxy, Q-io alkoxy, Q_io alkoxy(Q- ⁇ o)alkoxy, tri(Q- 4 )alkylsilyl(Q-6)alkoxy, Ci- 6 alkoxycarbonyl(Q- ⁇ o)alkoxy, Q.i 0 haloalkoxy, aryl(Q.
  • Alkenyl and alkynyl moieties can be in the form of straight or branched chains, and the alkenyl moieties, where appropriate, can be of either the (E or ⁇ -configuration. Examples are vinyl, allyl and propargyl.
  • alkenyl or alkynyl include those optional substituents given above for an alkyl moiety.
  • acyl is optionally substituted Q-6 alkylcarbonyl (for example acetyl), optionally substituted C 2 - 6 alkenylcarbonyl, optionally substituted C 2 -6 alkynylcarbonyl, optionally substituted arylcarbonyl (for example benzoyl) or optionally substituted heteroarylcarbonyl.
  • Halogen is fluorine, chlorine, bromine or iodine.
  • Haloalkyl groups are alkyl groups which are substituted with one or more of the same or different halogen atoms and are, for example, CF 3 , CF 2 C1, CF 3 CH 2 or CHF 2 CH 2 .
  • Haloalkenyl groups are alkenyl groups which are substituted with one or more of the same or different halogen atoms.
  • Aryl includes naphthyl, anthracyl, fluorenyl and indenyl but is preferably phenyl.
  • heteroaryl refers to an aromatic ring containing up to 10 atoms including one or more heteroatoms (preferably one or two heteroatoms) selected from O, S and N. Examples of such rings include pyridine, pyrimidine, furan, quinoline, quinazoline, pyrazole, thiophene, thiazole, oxazole and isoxazole.
  • heterocycle and heterocyclyl refer to a non-aromatic ring containing up to 10 atoms including one or more (preferably one or two) heteroatoms selected from O, S and N.
  • examples of such rings include 1,3-dioxolane, tetrahydrofuran and morpholine.
  • the optional substituents on heterocyclyl include Q- 6 alkyl as well a those optional substituents given above for an alkyl moiety.
  • Cycloalkyl includes cyclopropyl, cyclopentyl and cyclohexyl.
  • Cycloalkenyl includes cyclopentenyl and cyclohexenyl.
  • the optional substituents on cycloalkyl or cycloalkenyl include Q- 3 alkyl as well as those optional substituents given above for an alkyl moiety.
  • Carbocyclic rings include aryl, cycloalkyl and cycloalkenyl groups.
  • the optional substituents on aryl or heteroaryl are selected, independently, from halogen, nitro, cyano, NCS-, Q- 6 alkyl, Q- 6 haloalkyl, Ci- 6 alkoxy(Q- 6 )alkyl, C 2 - 6 alkenyl, C 2 - 6 haloalkenyl, - 6 alkynyl, C 3 .
  • substituents are independently selected from halogen, Q, 6 alkyl, Ci- 6 haloalkyl, Ci- 6 alkoxy(Q- 6 )alkyl, Q- 6 alkoxy, Ci- 6 haloalkoxy, Ci- 6 alkylthio, Q- 6 haloalkylthio, Q- 6 alkylsulfinyl, Q-6 haloalkylsulfinyl, Q- 6 alkylsulfonyl, Q- 6 haloalkylsulfonyl, - 6 alkenyl, C 2 - 6 haloalkenyl, C 2 -6 alkynyl, Q- 7 cycloalkyl, nitro, cyano, CO 2 H, Q- 6 alkylcarbonyl, Q- 6 alkoxycarbonyl, R 28 R 29 N or
  • dialkylamino substituents include those where the dialkyl groups together with the N atom to which they are attached form a five, six or seven- membered heterocyclic ring which may contain one or two further heteroatoms selected from O, N or S and which is optionally substituted by one or two independently selected (Q- 6 )alkyl groups.
  • heterocyclic rings are formed by joining two groups on an N atom, the resulting rings are suitably pyrrolidine, piperidine, thiomorpholine and morpholine each of which may be substituted by one or two independently selected (Ci- 6 ) alkyl groups.
  • Phenyl(Q--t.)alkyl is, for example, 1-phenyleth-l-yl, 2-phenyleth-l-yl, 2-phenylprop-2-yl, 3-phenylprop-l-yl, but is preferably benzyl. Analogous terms are to be interpreted in corresponding fashion.
  • the optional substituents on an alkyl moiety include one or more of halogen, nitro, cyano, HO 2 Ci- 10 alkoxy (itself optionally substituted by Q-io alkoxy), aryl(Q- 4 )alkoxy, Q- 10 alkylthio, Q- 10 alkylcarbonyl, Q-io alkoxycarbonyl, Ci- 6 alkylaminocarbonyl, di(Q- 6 alkylaminocarbonyl, (Q- 6 )alkylcarbonyloxy, optionally substituted phenyl, heteroaryl, aryloxy, arylcarbonyloxy, heteroaryloxy, heterocyclyl, heterocyclyloxy, C 3 - 7 cycloalkyl (itself optionally substituted with (Q- 6 )alkyl or halogen), C 3 - 7 cycloalkyloxy, Q- 7 cycloalkenyl, Q-e alkylsulfonyl, Q- 6 al
  • the optional substituents on alkenyl or alkynyl include one or more of halogen, aryl and C 3 - 7 cycloalkyl. It is more preferred that heterocyclyl is optionally substituted by Q- 6 alkyl.
  • the optional substituents for cycloalkyl include halogen, cyano and Q- 3 alkyl.
  • the optional substituents for cycloalkenyl include Q. 3 alkyl, halogen and cyano.
  • the method of the present invention preferably produces a compound of formula
  • R 1 is hydrogen, halogen, Q- 6 alkyl, Q- 6 alkenyl, - 6 alkynyl, Q- 6 cyanoalkyl, Q- 6 haloalkyl, Q-6 alkoxy, Q- 6 haloalkoxy, Ci- 6 alkylthio, Ci- 6 haloalkylthio, C 3 -6 cycloalkyl, C 3 - 7 cycloalkyl(Q- 4 )alkyl, Q- 6 alkoxy(Q- 6 )alkyl, cyano, nitro or SF 5 ;
  • A is Ci- 6 alkylene, Q-6 alkenylene , Ci- 6 alkylenoxy, oxy(Q- 6 )alkylene, Ci- 6 alkylena
  • R 7 is cyano, Q- 8 alkyl, Q- 8 haloalkyl, C ⁇ - 8 cyanoalkyl, C 2 - 6 alkenyl, C 2 - 6 alkynyl, C 3 - 7 cycloalkyl, C 3 . 7 halocycloalkyl, C 3 - 7 cyanocycloalkyl, Q- 3 alkyl(C 3 - 7 )cycloalkyl, Q- 3 alkyl(C 3 .
  • R 9 is cyano, nitro, Ci- 6 alkyl, Q- 6 haloalkyl, Q- 7 cycloalkyl, C 3 - 7 cycloalkyl(Q- e)alkyl,
  • R 10 is hydrogen, Q- 8 alkyl, Q- 6 haloalkyl, Q. 6 cyanoalkyl, Q- 6 alkenyl, Q- 6 alkynyl, Q- 7 cycloalkyl, Q- 6 haloalkenyl, Q_ 7 cycloalkyl(Q- 6 )alkyl, Ci- 6 alkoxy(Q- 6 )alkyl, Q- 6 alkoxycarbonyl, Ci- 6 alkylcarbonyl, Ci- 6 alkylaminocarbonyl, di(Q-6)alkylaminocarbonyl, phenyl (optionally substituted by halo, nitro, cyano, Q- 6 alkyl, Q- 6 haloalkyl, Q- 6 alkoxy or Ci- 6 haloalkoxy) or heteroaryl (optionally substituted by halo, nitro, cyano, Ci- 6 alkyl, Ci- 6 haloalkyl, Ci-6 alkoxy or Q- 6
  • R 8 is hydrogen, halogen, nitro, cyano, Q- 8 alkyl, Ci- 6 haloalkyl, Ci- 6 cyanoalkyl, - 6 alkenyl, Q- 6 alkynyl, Q- 7 cycloalkyl, C 2 - 6 haloalkenyl, Q- 7 cycloalkyl(Q- 6 )alkyl, Ci- 6 alkoxy(Q.
  • R 23 is Q-e alkyl or optionally substituted phenyl(Ci- 2 )alkyl;
  • R 24 and R 25 are, independently, hydrogen, Q- 8 alkyl or phenyl (optionally substituted by halo, nitro, cyano, Q- 6 alkyl, Q- 6 haloalkyl, - 6 alkoxy or Ci- 6 haloalkoxy);
  • R 15 is hydrogen, Q- 8 alkyl, Q-6 haloalkyl, Q-6 cyanoalkyl, - 6 alkenyl, -6 alkynyl, Q- 6 alkoxy(Q- 6 )alkyl, phenyl(Q-- ⁇ )alkyl (wherein the phenyl group is optionally substituted by halo, nitro, cyano, Q- 6 alkyl, Q- 6 haloalkyl, Q- 6 alkoxy or Q- 6 haloalkoxy), heteroaryl(Q--t)alkyl (wherein the heteroaryl group is optionally substituted by halo, nitro, cyano, Q- 6 alkyl, Q- 6 haloalkyl, Q-6 alkoxy or Q- 6 haloalkoxy), heterocyclyl (optionally substituted by halo, nitro, cyano, Q-6 alkyl, Q- 6 haloalkyl, Q- 6 alkoxy or Ci- 6 hal
  • R 19 is Ci- 6 alkyl, Q-e haloalkyl or phenyl (optionally substituted by halo, nitro, cyano, Ci- 6 alkyl, Q- 6 haloalkyl, Ci-6 alkoxy or Q- 6 haloalkoxy);
  • R 16 and R 17 are, independently, hydrogen, Q- 8 alkyl, - 7 cycloalkyl, - 6 alkenyl, - 6 alkynyl, Q- 7 cycloalkyl(Q- 4 )alkyl, Q- ⁇ haloalkyl, Q- 6 alkoxy(Q- 6 )alkyl, Q- 6 alkoxycarbonyl, or R 16 and R 17 together with the N atom to which they are attached form a five, six or seven-membered heterocyclic ring which may contain one or two further hetero atoms selected from O, N or S and which may be optionally substituted by one or two Ci- 6 alkyl groups;
  • R 18 and R 11 are, independently, Ci- 6 alkyl or phenyl(Q- 2 )alkyl (wherein the phenyl group is optionally substituted by halo, nitro, cyano, Ci- 6 alkyl, Q-6 haloalkyl, Q- 6 alkoxy or Ci-
  • R 26 and R 27 are, independently, hydrogen, Q- 8 alkyl, Q- 7 cycloalkyl, - 6 alkenyl, -6 alkynyl, -6 haloalkyl, Q- 6 alkoxy(Q- 6 )alkyl, Q- 6 alkoxycarbonyl(Q-6)alkyl, carboxy(Q-6)alkyl or phenyl(Q- 2 )alkyl; or R 26 and R 27 together with the N atom to which they are attached form a five, six or seven-membered heterocyclic ring which may contain one or two further heteroatoms selected from O, N or S and which may be optionally substituted by one or two Ci- 6 alkyl groups.
  • Q- 3 alkoxy, -C(O)- or Q- 4 alkyleneoxy (which may be optionally substituted by Q- 3 alkyl).
  • A is Q- 2 alkyl-substituted Q- 4 alkylene, fluoro- substituted Q- 4 alkylene, methoxy-substituted Q- 4 alkylene, -C(O)- or Q- 4 alkyleneoxy; still more preferably A is Q- 2 alkyl-substituted Q- alkylene, fluoro-substituted C M alkylene or methoxy-substituted Q- alkylene.
  • A is CH(CH 3 )CH 2 , CH 2 CH(CH 3 ), CH(CH 3 ), CHF, CH(OCH 3 ) or CH(CH 3 )O; yet further preferred is for A to be CH(CH 3 )CH 2 , CH 2 CH(CH 3 ), CH(CH 3 ), CHF or CH(CH 3 )O; it is especially preferred that A is CHF, CH(OCH 3 ) or CH(CH 3 ); and most preferably A is CHF or CH(CH 3 ).
  • B is preferably N.
  • Z is preferably O or S, more preferably O. It is preferred that R 1 is hydrogen, halogen, Ci- 6 alkyl, Q- 6 cyanoalkyl, Ci- 6 haloalkyl, - 7 cycloalkyl(Q- )alkyl, Q- 6 alkoxy(Q- 6 )alkyl, Q- 6 alkenyl, Q-6 alkynyl, Q-6 alkoxy, Q- 6 haloalkoxy, Ci- 6 alkylthio, Ci- 6 haloalkylthio, Q- 6 cycloalkyl, cyano, nitro or SF 5 .
  • R 1 is more preferably hydrogen, halogen, Q- 6 alkyl, C 2 -6 alkenyl, Ci-6 haloalkyl, Q- 6 alkoxy, Ci- 6 haloalkoxy, Q- 6 alkylthio, Q- 6 haloalkylthio, C 3 - 6 cycloalkyl, cyano, nitro or SF 5 .
  • R 1 is hydrogen, halogen, Ci- 6 alkyl, Q- 6 haloalkyl, Q- 6 alkoxy(Q- 6 )alkyl, - 6 alkenyl, Q- 6 alkoxy, Q- 6 haloalkoxy, Q-6 alkylthio, Ci- 6 haloalkylthio, - 6 cycloalkyl or cyano.
  • R 1 is halogen, Q- 6 alkyl, Q- 6 haloalkyl, Ci- 6 alkoxy or Ci- 6 haloalkoxy.
  • R 2 is hydrogen, halogen, Q- 6 alkyl, Q- 6 haloalkyl, Q- 6 alkoxy (Q- 6 )alkyl, Q- 6 alkoxy, Q- 6 haloalkoxy, Ci- 6 alkylthio or SF 5 ; or R 1 and R 2 together with the atoms to which they are attached form a cyclopentane or benzene ring optionally substituted by Ci-6 alkyl, Q-6 haloalkyl or halogen.
  • R 2 is even more preferably hydrogen, halogen, Ci- 6 alkyl, Q- 6 haloalkyl, Q- 6 alkoxy,
  • R 2 is most preferably halogen, Ci- 6 alkyl, Ci- 6 haloalkyl, Q- 6 alkoxy, Q- 6 alkoxy (Q- 6 )alkyl or Ci- 6 haloalkoxy.
  • R 3 is hydrogen, Q- 10 alkyl, Ci- 6 alkylcarbonyloxy(Q- 6 )alkyl, benzoyloxymethyl (where the phenyl ring is optionally substituted with halogen or CM alkyl), Q- 6 alkoxy(Q- 6 )alkyl (where the alkyl group is optionally substituted by aryl or C M alkoxycarbonyl), Q- 6 alkenyloxy(Q- 4 )alkyl, - 6 alkynyloxy(Q- 4 )alkyl, benzyloxy(Q- )alkyl (where the phenyl ring is optionally substituted with halogen or Q- 4 alkyl), Q- 7 cycloalkyl(Q-- t )alkyl, heteroaryl(Q- 3 )alkyl (where the heteroaryl group is optionally substituted with halogen), tri(C 1 - 4 )alkylsilyl(C 1 - 6
  • R 3 is hydrogen, Ci- 6 alkyl, Q- 6 alkylcarbonyloxymethyl, benzoyloxymethyl (where the phenyl ring is optionally substituted with halogen or CM alkyl), Ci- 6 alkoxymethyl, - 6 alkenyloxymethyl, Q- 6 alkynyloxymethyl, benzyloxymethyl (where the phenyl ring is optionally substituted with halogen or Q- alkyl), - 6 alkynyl(Q- 6 )alkyl (especially propargyl) or Q_ ⁇ o alkylcarbonyl.
  • R 3 is more preferably hydrogen, Q- 6 alkyl, Ci- 6 alkoxy(Q-6)alkyl, benzyloxymethyl or benzoyloxymethyl; or alternatively R 3 may be Q-e alkylcarbonyloxymethyl.
  • R 3 is hydrogen, Q- 6 alkyl, Q- 6 alkylcarbonyloxymethyl or Q- 6 alkoxymethyl. It is preferred that R 4 , R 5 and R 6 are, independently, hydrogen, halogen, Ci- 6 alkyl,
  • Q- 6 haloalkyl Ci- 6 alkoxy, Q-e haloalkoxy, Q- 6 alkylthio, Ci- 6 haloalkylthio, Q- 6 alkylsulfinyl, Q_ 6 haloalkylsulfinyl, Q- 6 alkylsulfonyl, Q- 6 haloalkylsulfonyl, cyano, nitro, Q- 6 alkylcarbonyl or Ci-6 alkoxycarbonyl.
  • R 4 , R 5 and R 6 are, independently, hydrogen, halogen or Q- 3 alkyl.
  • R 4 , R 5 and R 6 are, independently, hydrogen or halogen (especially fluorine). It is preferred that R 7 is cyano, Q- 8 alkyl, Q- 8 haloalkyl, Q- 8 cyanoalkyl, C 3 - 7 cycloalkyl(Q- 6 )alkyl, C 5 - 6 cycloalkenyl(Q- 6 )alkyl, Ci- 6 alkoxy(Ci- 6 )alkyl, C 3 - 6 alkenyloxy(C ⁇ - 6 )alkyl, Q- 6 alkynyloxy(C ⁇ - 6 )alkyl, aryloxy(Ci- 6 )alkyl, Ci- 6 carboxyalkyl, Q- 6 alkylcarbonyl(Ci- 6 )alkyl, C 2 - 6 alkenylcarbonyl(C ⁇ - 6 )alkyl, C 2 - 6 a ⁇ kynylcarbonyl(Q- 6
  • R 15 is hydrogen, Q- 8 alkyl, Ci-6 haloalkyl, Ci-6 cyanoalkyl, Q- 6 alkoxy(Q- 6 )alkyl, phenyl(Q-- ⁇ )alkyl, (wherein the phenyl group is optionally substituted by halo, nitro, cyano, Q- 6 alkyl, Ci- 6 haloalkyl, Q- 6 alkoxy or Q- 6 haloalkoxy), heteroaryl(Q- 4 )alkyl (wherein the heteroaryl group is optionally substituted by halo, nitro, cyano, Q- 6 alkyl, Q- 6 haloalkyl, Q- 6 alkoxy or Q- 6 haloalkoxy), heterocyclyl(Q_4)alkyl (wherein the heterocyclyl group is optionally substituted by halo, nitro, cyano
  • R 7 is more preferably Q- 8 alkyl, Q- 8 haloalkyl, Q- 8 cyanoalkyl, Q- 6 alkenyl, Q- 6 alkynyl, Q- cycloalkyl, Q_ 7 halocycloalkyl, Q- 7 cyanocycloalkyl, Q- 3 alkyl(Q.
  • R 15 is Q_ 8 alkyl, Ci-6 haloalkyl
  • R 19 is Q- 6 alkyl, Ci- 6 haloalkyl or phenyl (optionally substituted by halo, nitro, cyano, Q- 6 alkyl, Q- 6 haloalkyl, Q- 6 alkoxy or Q- 6 haloalkoxy)
  • R 16 and R 17 are, independently, hydrogen, Q- 8 alkyl, Q- 7 cycloalkyl, Q- 6 alkenyl, Q- 6 alkynyl, C 3 .
  • R 7 cycloalkyl(C ⁇ - 4 )alkyl, C 2 - 6 haloalkyl, Q-6 alkoxy(Q- 6 )alkyl, Q-6 alkoxycarbonyl, or R 16 and R 17 together with the N atom to which they are attached form a five, six or seven-membered heterocyclic ring which may contain one or two further heteroatoms selected from O, N or S and which may be optionally substituted by one or two Q- 6 alkyl groups; and R 18 is Ci- 6 alkyl or phenyl(Q- 2 )alkyl (wherein the phenyl group is optionally substituted by halo, nitro, cyano, Ci- 6 alkyl, Q- 6 haloalkyl, Ci-6 alkoxy or Q-6 haloalkoxy); and R 7 is more preferably Q- 8 alkyl, Q- 8 haloalkyl, Q- 8 cyanoalkyl, Q-7 cycloalkyl, Q.
  • R 7 is Q- 8 alkyl, Q- 8 haloalkyl, Q- 8 cyanoalkyl, Q-7 cycloalkyl(Q- 6 )alkyl, - 6 cycloalkenyl(Q- 6 )alkyl, Ci- 6 alkoxy(Q- 6 )alkyl, Q-e alkenyloxy(Q- 6 )alkyl, - 6 alkynyloxy(Q- 6 )alkyl, _tryloxy(Q- 6 )alkyl, Q- 6 carboxyalkyl, Q-6 alkylcarbonyl(Q- 6 )alkyl, Q- ⁇ alkenylcarbonyl(Q- 6 )alkyl, Q- 6 alkynylcarbonyl(Q-6)alkyl, Q- 6 alkoxycarbonyl(Q- 6 )alkyl, - 6 alkenyloxycarbonyl(Q_ 6 )alkyl, Q-6 alkynyloxy
  • heterocyclyl- (CM) alkyl wherein the heterocyclyl group is optionally substituted by halo, nitro, cyano, Q- 6 alkyl, Q- 6 haloalkyl, Ci- 6 alkoxy or Q_6 haloalkoxy
  • R 16 and R 17 are, independently, hydrogen, Q- 8 alkyl, - 7 cycloalkyl(Q- 4 )alkyl, Q- 6 haloalkyl, Q. 6 alkoxy(Q- 6 )alkyl, Q.
  • R 18 is phenyl(Q_ 2 )alkyl (wherein the phenyl group is optionally substituted by halo, nitro, cyano, Q- 6 alkyl, Q. 6 haloalkyl, Ci- 6 alkoxy or Ci-e haloalkoxy) or Q-e alkyl.
  • R 7 is Q- 8 alkyl, Q- 8 haloalkyl, Q_ 8 cyanoalkyl, Q- 6 alkoxy (Q- 6 ) alkyl, Q- 7 cycloalkyl, Q- 3 alkyl (Q. 7 ) cycloalkyl, heterocyclyl (optionally substituted by halo, nitro, cyano, Q_ 6 alkyl, Ci- 6 haloalkyl, Q. 6 alkoxy or Q- 6 haloalkoxy) or di(Q. 8 )alkylamino. It is yet more preferred that R 7 is Q- 8 alkyl, Q- 8 haloalkyl, Q. 8 cyanoalkyl, Q.
  • R 7 is most preferably Q- 8 alkyl, Q- 8 haloalkyl, Q- 8 cyanoalkyl, Q- 7 cycloalkyl, Q- 3 alkyl(C 3 - 7 )cycloalkyl, Q- 6 alkoxy(Q- 6 )alkyl or R 16 R 17 N; where R 16 andR 17 are, independently, C ⁇ _ 8 alkyl or together with the N atom to which they are attached form a five, six or seven-membered heterocyclic ring which may contain one further heteroatom selected from O, N or S and which may be optionally substituted by one or two Ci- 6 alkyl groups.
  • R is hydrogen, halogen, nitro, cyano, Q- 8 alkyl, - 6 haloalkyl, Ci- 6 cyanoalkyl, Q- 7 cycloalkyl(Q- 6 )alkyl, Q- 6 alkoxy(Q- 6 )alkyl, Q- 6 alkoxycarbonyl(Q. 6 )alkyl, Q-6 a ⁇ ky ⁇ carbonyl(Q.
  • heteroaryl(Q- 6 )alkyl wherein the heteroaryl group is optionally substituted by halo, nitro, cyano, Q-6 alkyl, Ci- 6 haloalkyl, Ci- 6 alkoxy or Q- 6 haloalkoxy), Q- 6 alkenyl, Q-6 haloalkenyl, -6 alkynyl, C 3 - 7 cycloalkyl, Q.
  • R 8 is hydrogen, halogen, Q- 8 alkyl or Ci- 6 haloalkyl.
  • R 9 is cyano, nitro, Ci- 6 alkyl, Q. 6 haloalkyl, Q- 7 cycloalkyl(Q- 6 )alkyl, Q- 7 cycloalkyl, CH 2 (Q- 6 )alkenyl, CH 2 (Q- 6 )alkynyl, phenyl
  • R 10 is hydrogen, Q- 8 alkyl, Q- 6 haloalkyl, Q-6 cyanoalkyl, Q- 6 alkenyl, Q-6 haloalkenyl, Q- ⁇ alkynyl, Q- 7 cycloalkyl, Q- 7 cycloalkyl(Q-6)alkyl, Ci-6 alkoxy(Q-6)alkyl, Q.
  • R 10 is hydrogen, Q- 8 alkyl or Q- 6 haloalkyl.
  • R 7 may be an electron-withdrawing group, such as haloalkyl (in particular a poly-rhalogenated group such as QF 7 ).
  • Compounds of formula (II) are either known compounds or may be prepared from commercially available starting materials by methods described in the literature (see, for example, C. Oliver Kappe, Robert Flammang, and Curt Wentrup, Heterocycles, Vol. 37, No. 3, 1615, (1994); A. Adams and R. Slack, J. Chem. Soc, 3061, (1959); and Ronald Ehackler, Kenneth W. Burow, Jr., Sylvester V. Kaster and David I. Wickiser, J. Heterocyclic Chem, 26, 1575, (1989)).
  • a compound of formula (HI) in which L is OH (Ilia) may be prepared by hydrolysis of the corresponding compound (lTlb) in which L is Ci- 6 alkyl, by a method known in the art.
  • the hydrolysis may be carried out under neutral, basic or acidic conditions; the conditions should be chosen such that substituent R 7 is unchanged during the hydrolysis reaction.
  • Compounds of formula (nib) are capable of ready hydrolysis under different conditions, as known in the literature.
  • Suitable compounds of formula (IDb) may be selected, for example, by reference to Theodora W. Greene, Protective Groups in Organic Synthesis, Chapter 5, John Wiley and Sons, New York, 1981.
  • a compound of formula (Hla) may be converted to for instance an acid chloride, anhydride or chloroformate suitable for use in the method of the present invention; such procedures are well known and are described, for example, in J. March, Advanced Organic Chemistry, Third Edition, John Wiley and Sons, New York, 1985, pages 370-376 and references therein.
  • compounds of formula ( ⁇ i)/(ffla)/(I ⁇ Tb) may be prepared by cyclisation of a compound of formula (V):
  • R 7 may be an atom or group which itself may be converted into other functional groups; procedures are known in the literature for such transformations involving benzoxazoles and benzothiazoles (for example, Lazer, Edward S., Adams, Julian; Miao, Clara K.; Farina, Peter, Eur. Pat. Appl. EP0535521).
  • R may contain atoms or groups which may be replaced by other moieties under known conditions.
  • a compound of formula (N) may be prepared by reduction of a compound of formula (NI):
  • a compound of formula (VI), wherein Z is oxygen, may be prepared by the nitration of a compound of formula (NH):
  • a compound of formula (NI) in which Z is sulfur may be prepared from a compound of formula (NI) in which Z is oxygen, using conditions similar to those described by J. Scheigetz, R. Zamboni and B. Roy, Synth. Commun., 25 (1995) (18), pages 2791-2806.
  • a compound of formula (NI) in which Z is nitrogen may be prepared from a compound of formula (NH) by a sequence of acylation, nitration and deacylation, using conditions known in the art.
  • R , R and R are each independently selected from alkyl groups, preferably Q-Q alkyl groups, more preferably either methyl or ethyl, most preferably methyl such as in the preferred reagent Me 3 Al.
  • Suitable solvents for the reaction include toluene, benzene, hexane and other inert hydrocarbons. Selection of an appropriate solvent for given reactants (H) and (HI) is well within the capabilities of the average person skilled in the art.
  • the method of the invention is suitably effected at a fairly high temperature, for instance between about 40°C and 120°C, more preferably between about 50°C and 100°Q most preferably between about 70°C and 100°C.
  • Reaction times may vary, but in general the reaction will be completed in between 2 and 8 hours, more typically between 2 and 4 hours.
  • the reaction mixture may suitably be left to stand at room temperature for between 12 and 48 hours, then worked up prior to product isolation.
  • between 1 and 1.2 molar equivalents of the trialkyl-aluminium agent may be used for between 1 and 1.2 molar equivalents of the amine reactant (H).
  • Suitable reaction conditions may in particular be derived from the published literature on the Weinreb reaction (supra).
  • the reactant (HI) is preferably added to a pre-prepared mixture of the amine isothiazole (JJ) and the trialkyl-aluminium agent.
  • a second aspect of the present invention provides a dialkylaluminium intermediate compound (X):
  • This intermediate has the general formula (H) but with the group A1-R 50 R 51 attached to the amine nitrogen.
  • R 50 and R 51 are as defined above in connection with the trialkyl-aluminium agent.
  • a third aspect of the present invention provides a method for the preparation of a compound of formula (I) as defined above, which method involves reacting a compound of formula (HI) (also as defined above) with the intermediate compound (X) of the second aspect of the invention.
  • a 3-necked round bottomed flask was pre-purged with nitrogen for 15 minutes and the nitrogen purging was continued during the subsequent reaction.
  • the mixture was refluxed for 2 hours at 94°C to 96°C (pressure of hexanes in solvent mixture). It was then cooled slightly and a sample taken for monitoring the reaction.
  • the phases were then separated - a little white solid present in the (lower) aqueous phase caused slight interference with separation.
  • the aqueous phase was re-extracted with more ethyl acetate (2 x 250 ml).
  • the combined organic phase (containing some of the white solid) was washed with saturated aqueous ammonium chloride (500 ml) - this possibly removed some of the solid into solution, but was still a slow separation - then brine (1 x 500 ml).

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Toxicology (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)

Abstract

Method for preparing a compound (I): from the corresponding isothiazole amine and for example an ester, using a trialkyl-aluminium compound R?50R51R52¿AI where R?50, R51 and R52¿ are each independently C¿1-10? alkyl. The method is particularly suitable for use when the ester is base- and/or nucleophile-sensitive, especially when R?7¿ is an electron withdrawing group. Also provided is a trialkyl-aluminium intermediate compound formed during the method.

Description

ACYLATION OF AMINO-ISOTHIAZOLES USING TRIA KY-AUMINIUM AGENTS
This invention relates to a method for preparing an isothiazole derivative. Certain compounds, comprising an isothiazole ring system linked to a second heteroaryl ring system via an amide or analogous linkage, are known from WO-95/31448, WO-97/18198, WO-98/02424, WO-98/05670, WO-98/17630 and WO-00/06566. Further examples of such compounds are given in co-pending UK patent applications nos. 0002031.3, 0002035.4, 0002036.2 and 0002041.2. Some of the compounds have pesticidal (which includes fungicidal, insecticidal, acaricidal, molluscicidal and/or nematicidal) activity. Particular examples of such compounds are those of the general formula (I):
Figure imgf000002_0001
wherein A is optionally substituted Q.6 alkylene, optionally substituted C .6 alkenylene, optionally substituted C2.6 alkynylene, optionally substituted cycloalkylene, optionally substituted Q-6 alkylenoxy, optionally substituted oxy(Q-6)alkylene, optionally substituted Cι-6 alkylenethio, optionally substituted thio(C1-6)alkylene, optionally substituted Ci-6 alkylenamino, optionally substituted amino(Cι-6)alkylene, optionally substituted [Cι-6 alkyleneoxy(Cι-6)alkylene], optionally substituted [Cι-6 alkylenethio(Cι-6)alkylene], optionally substituted [Q-6 alkylenesulfinyl(Cj.-6)alkylene], optionally substituted [Q-6 alkylenesulfonyl(C1-6)alkylene] or optionally substituted [Q-6 alkyleneamino(Cι-6)alkylene]; B is N, N-oxide or CR8;
Z is O, S orNR10;
R1 is hydrogen, halogen, optionally substituted Q-6 alkyl, optionally substituted C2-6 alkenyl, optionally substituted C2-6 alkynyl, optionally substituted -6 alkoxy, optionally substituted Q-6 alkylthio, optionally substituted C3-7 cycloalkyl, cyano, nitro or SF5; R2 is hydrogen, halogen, optionally substituted Q-6 alkyl, optionally substituted C2-6 alkenyl, optionally substituted C2-6 alkynyl, optionally substituted Ci-6 alkoxy, optionally substituted d-β alkylthio, optionally substituted -6 alkylsulfmyl, optionally substituted Q-6 alkylsulfonyl, cyano, nitro, formyl, optionally substituted Ci-6 alkylcarbonyl, optionally substituted Q-6 alkoxycarbonyl, SF5 or RnON=C(R12); or R1 and R2 together with the atoms to which they are attached may be joined to form a five, six or seven-membered saturated or unsaturated, carbocylic or heterocyclic ring which may contain one or two heteroatoms selected from O, N or S and which is optionally substituted by Q-6 alkyl, Q-6 haloalkyl or halogen; R3 is hydrogen, optionally substituted Q.io alkyl, optionally substituted [C -6 alkenyl(Q.6)alkyl], optionally substituted [C2-6 alkynyl(Q-6)alkyl], optionally substituted C3-7 cycloalkyl, optionally substituted Q-10 alkylcarbonyl, optionally substituted Q-io alkoxycarbonyl, formyl, optionally substituted Q-ioalkylan-rinocarbonyl, optionally substituted &(Q-ιo)alkylaminocarbonyl, optionally substituted phenoxycarbonyl, optionally substituted Q-6 alkylthio, optionally substituted Q-6 alkylsulfinyl, optionally substituted Q-6 alkylsulfonyl, optionally substituted Q-6 arylthio, optionally substituted Ci-6 arylsulfinyl, optionally substituted Q-6 arylsulfonyl or R13R14NS(O)p; p is 0, 1 or 2;
R4, R5 and R6 are, independently, hydrogen, halogen, optionally substituted Q-6 alkyl, optionally substituted Q-6 alkoxy, optionally substituted Q-6 alkylthio, optionally substituted Q-6 alkylsulfinyl, optionally substituted Q-6 alkylsulfonyl, cyano, nitro, optionally substituted Q-6 alkylcarbonyl, optionally substituted Q-6 alkoxycarbonyl or SF5; R7 is hydrogen, halogen, cyano, optionally substituted Q- o alkyl, optionally substituted C2-20 alkenyl, optionally substituted C2-20 alkynyl, optionally substituted C3- cycloalkyl, optionally substituted C5-6 cycloalkenyl, formyl, optionally substituted Q-20 alkoxycarbonyl, optionally substituted Q- o alkylcarbonyl, aminocarbonyl, optionally substituted Q-20 alkylaminocarbonyl, optionally substituted di(Q-2o)alkylaminocarbonyl, optionally substituted aryloxycarbonyl, optionally substituted arylcarbonyl, optionally substituted arylaminocarbonyl, optionally substituted N-(C1-6)alkyl-N-arylarninocarbonyl, optionally substituted diarylaminocarbonyl, optionally substituted heteroaryloxycarbonyl, optionally substituted heteroarylcarbonyl, optionally substituted heteroarylaminocarbonyl, optionally substituted N-(C1-6)alkyl-N-heteroarylaminocarbonyl, optionally substituted diheteroarylaminocarbonyl, optionally substituted phenyl, optionally substituted heteroaryl, optionally substituted heterocyclyl, SH, optionally substituted Q.20 alkylthio, optionally substituted Q_20 alkylsulfinyl, optionally substituted Q-2o alkylsulfonyl, optionally substituted arylthio, optionally substituted arylsulfinyl, optionally substituted arylsulfonyl, R15O, R16R17N or R18ON=C(R19); R8 is hydrogen, halogen, nitro, cyano, optionally substituted Q-g alkyl, optionally substituted C2-6 alkenyl, optionally substituted C2.6 alkynyl, optionally substituted C3-7 cycloalkyl, optionally substituted Q-6 alkoxycarbonyl, optionally substituted Ci-6 alkylcarbonyl, optionally substituted Q-6 alkylaminocarbonyl, optionally substituted di(Q-6)alkylaminocarbonyl, optionally substituted phenyl or optionally substituted heteroaryl;
R9 is hydrogen, cyano, nitro, optionally substituted Ci-6 alkyl, optionally substituted C3-7 cycloalkyl, optionally substituted (C2-6)alkenyl(Q-6)alkyl, optionally substituted (C2-6)alkynyl(Q-6)alkyl, optionally substituted phenyl, optionally substituted heteroaryl, optionally substituted Q-6 alkylcarbonyl, optionally substituted Q-6 alkoxycarbonyl, optionally substituted Q-6 alkylamino, optionally substituted di(Q-6)alkylamino, optionally substituted Q-6 alkylcarbonylamino, optionally substituted Ci-6 alkoxycarbonylamino, optionally substituted Q-6 alkoxy, optionally substituted Ci-6 alkylthio, optionally substituted Ci-6 alkylsulfinyl, optionally substituted Q-6 alkylsulfonyl, optionally substituted arylthio, optionally substituted arylsulfinyl, optionally substituted arylsulfonyl or Ci-6 alkylcarbonyloxy;
R10 is hydrogen, cyano, optionally substituted Q-8 alkyl, optionally substituted [C2-6 alkenyl(C1-6)alkyl], optionally substituted [C2-6 alkynyl(Q-6)alkyl], optionally substituted C3-7 cycloalkyl, optionally substituted [C3- cycloalkyl(Cι-6)alkyl], Q-6 alkoxy(Q-6)alkyl, optionally substituted Q-6 alkoxycarbonyl, optionally substituted Q-6 alkylcarbonyl, optionally substituted Q-6 alkylaminocarbonyl, optionally substituted di(Q-6)alkyl-uminocarbonyl, optionally substituted phenyl, optionally substituted heteroaryl, optionally substituted alkylsulfonyl or optionally substituted arylsulfonyl;
R11 and R18 are, independently, hydrogen, optionally substituted phenyl (Q_2)alkyl or optionally substituted.Q-20 alkyl;
R12 and R19 are, independently, hydrogen, optionally substituted phenyl or optionally substituted Q-6 alkyl;
R13 and R14 are, independently, optionally substituted Ci-6 alkyl; or R13 and R14 together with the N atom to which they are attached form a five, six or seven-membered heterocyclic ring which may contain one or two further heteroatoms selected from O, N and S and which is optionally substituted by one or two independently selected Q-6 alkyl groups;
R15 is hydrogen, optionally substituted Q-20 alkyl, optionally substituted [C2-2o alkenyl(Q-6)alkyl], optionally substituted [C2-20 alkynyl(Q-6) alkyl], optionally substituted C3. cycloalkyl, optionally substituted aryl, optionally substituted heteroaryl, optionally substituted heterocyclyl, (Q-6)alkylCH=N, optionally substituted arylCH=N, optionally substituted [aryl(Q-6)alkyl]CH=N, optionally substituted heteroarylCH=N, optionally substituted [heterocyclyl(Q-6)alkyl]CH=N, optionally substituted arylC(CH )=N, optionally substituted heteroarylC(CH3)=N or optionally substituted di(Q-6)alkylC==N; and
R16 and R17 are, independently, hydrogen, optionally substituted Q-20 alkyl, optionally substituted C3-7 cycloalkyl, optionally substituted [C2-20 alkenyl(Q-6)alkyl], optionally substituted [C2-2o alkynyl(Q-6)alkyl], optionally substituted Ci-20 alkoxycarbonyl, optionally substituted phenoxycarbonyl, formyl, optionally substituted Q-2o alkylcarbonyl, optionally substituted Q-2o alkylsulfonyl or optionally substituted phenylsulfonyl. Methods for preparing certain compounds of formula (I) are disclosed in WO-00/06566; they involve acylation of an amino-isothiazole (which provides the left-hand ring system) with an appropriate acid, acid chloride or acid anhydride to provide the right-hand ring system and an appropriate linking group. The reaction is carried out in the presence of an alkoxide base such as sodium methoxide or potassium tertiary-butoxide. A first aspect of the present invention provides an alternative method for the preparation of a compound of formula (I) which makes use of so-called "Weinreb" chemistry. [Jeremy I Levin, Edward Turos and Steven M Weinreb; Synthetic Communications, 12(13), 989-993 (1982) - 'An Alternative Procedure for the Aluminum-Mediated Conversion of Esters to Amides'; Anwer Basha, Michael Lipton and Steven M Weinreb; Tetrahedron Letters, 18(48), 4171-4174 (1977) - 'A Mild, General Method for the Conversion of Esters to A-rnides'; Michael F Lipton, Anwer Basha, Steven M Weinreb; Organic Syntheses, 59, 49-53 (1979) - 'Conversion of Esters to Amides with Dimethylaluminum Amides: N,N-Dimethylcyclohexanecarboxamide'.] The "Weinreb" reaction has not previously been used to prepare compounds of formula (I). It utilises a trialkyl-aluminium agent to complex with an amine nitrogen atom and hence activate the nitrogen to electrophilic attack, for instance by an ester so as to form an amide product. The reaction avoids the use of strongly acidic or basic conditions, under which certain reagents can be susceptible to nucleophilic attack, ring opening and other undesired reactions.
The method of the present invention comprises reacting together an amino-isothiazole of the general formula (II):
Figure imgf000006_0001
(π) in which R1, R2 and R3 are as defined above in relation to formula (I), and a compound
(conveniently an ester) of the general formula (HI):
Figure imgf000006_0002
(HI) in which A, B, Z and R4 - R7 are as defined above in relation to formula (I) and L is a leaving group such as halo (in particular chloro) or R30-O-, where R30 is hydrogen or a Q-6 alkyl group, in the presence of a trialkyl-aluminium compound R50R51R52A1 where R50, R51 and R52 are each independently selected from Q-io, preferably Q-6, alkyl.
This method can provide a ready means of preparing compounds of formula (I), in particular where the requisite reactant (IU) is base- or nucleophile-sensitive. It may be of particular use where the reactant (III) is a benzoxazole derivative (ie, B is nitrogen and Z is oxygen) such as a benzoxazole ester (ie, L is R30-O-), especially where the substituent R7 is electron withdrawing.
Examples of compounds of formula (I), which may be produced using the method of the present invention, are disclosed in WO-00/06566 and in co-pending UK patent applications nos. 0002031.3, 0002035.4, 0002036.2 and 0002041.2. Some compounds of formula (I) have been found to be pesticidally (in particular insecticidally and/or fungicidally) active.
Preferred compounds (I) will now be described. It is to be understood that certain compounds of formula (I) may exist in different geometrically or optically isomeric or tautomeric forms; this invention extends to all such isomers and tautomers and mixtures thereof in all proportions as well as isotopic forms such as deuterated compounds. One group of preferred compounds of formula (I), which may be prepared using the method of the present invention, is a group wherein: A is optionally substituted Ci-6 alkylene, optionally substituted C2-6 atkenylene, optionally substituted C2-6 alkynylene, optionally substituted Q-6 alkylenoxy, optionally substituted oxy(Ci-6)alkylene, optionally substituted Q-6 alkylenethio, optionally substituted thio(Q-6)alkylene, optionally substituted Q-6 alkylenamino, optionally substituted arnino-(Q-6)alkylene, optionally substituted [Q-6 alkyleneoxy(Q-6)alkylene], optionally substituted [Q-6 alkylenethio(Q-6)alkylene], optionally substituted [Ci-6 alkylenesulfinyl(Q-6)alkylene], optionally substituted [Ci-6 alkylenesulfonyl(Q-6)alkylene] or optionally substituted [Q-6 a-kyleneamino(Q-6)alkylene]; B is N, N-oxide or CR8; Z is O. S or NR10;
R3is hydrogen, optionally substituted Q-10 alkyl, optionally substituted [C2-6 alkenyl(Ci-6)alkyl], optionally substituted [C2-6 alkynyl(Ci-6)alkyl], optionally substituted C3-7 cycloalkyl, optionally substituted Q-10 alkylcarbonyl, optionally substituted C^o alkoxycarbonyl, formyl, optionally substituted Q-io alkylaminocarbonyl, optionally substituted di(Q-ιo)alkylanτinocarbonyl, optionally substituted phenoxycarbonyl, optionally substituted Ci-6 alkylthio, optionally substituted Q-6 alkylsulfinyl, optionally substituted Q-e alkylsulfonyl, optionally substituted Q-6 arylthio, optionally substituted Q-6 arylsulfinyl, optionally substituted Q-6 arylsulfonyl or R13R14NS;
R4, R5 and R6 are, independently, hydrogen, halogen, optionally substituted Q-6 alkyl, optionally substituted Q-6 alkoxy, optionally substituted Ci-6 alkylthio, optionally substituted Q-6 alkylsulfinyl, optionally substituted Q-6 alkylsulfonyl, cyano, nitro, optionally substituted Q-6 alkylcarbonyl, optionally substituted Q-6 alkoxycarbonyl or SF5;
R7 is hydrogen, halogen, cyano, optionally substituted Q.2o alkyl, optionally substituted C -2o alkenyl, optionally substituted C2-20 alkynyl, optionally substituted C3-7 cycloalkyl, optionally substituted C5-6 cycloalkenyl, formyl, optionally substituted Q-2o alkoxycarbonyl, optionally substituted Q-2o alkylcarbonyl, aminocarbonyl, optionally substituted Q-2o alkylaminocarbonyl, optionally substituted di(Q-2o)alkylaminocarbonyl, optionally substituted aryloxycarbonyl, optionally substituted arylcarbonyl, optionally substituted arylaminocarbonyl, optionally substituted N-alkyl-N-arylaminocarbonyl, optionally substituted diarylaminocarbonyl, optionally substituted heteroaryloxycarbonyl, optionally substituted heteroarylcarbonyl, optionally substituted heteroarylaminocarbonyl, optionally substituted alkylheteroarylaminocarbonyl, optionally substituted diheteroarylaminocarbonyl, optionally substituted phenyl, optionally substituted heteroaryl, optionally substituted heterocyclyl, R15O, HS, optionally substituted Q.2o alkylthio, optionally substituted Q-20 alkylsulfinyl, optionally substituted Ci-2o alkylsulfonyl, optionally substituted arylthio, optionally substituted arylsulfinyl, optionally substituted arylsulfonyl, R16R17N or R18ON=C(R19); R1 is hydrogen, halogen, optionally substituted Ci-6 alkyl, optionally substituted C2-6 alkenyl, optionally substituted C2-6 alkynyl, optionally substituted Ci-6 alkoxy, optionally substituted Ci-6 alkylthio, optionally substituted C3-7 cycloalkyl, cyano, nitro or SF5;
R2 is hydrogen, halogen, optionally substituted Q-6 alkyl, optionally substituted C2-6 alkenyl, optionally substituted C2-6 alkynyl, optionally substituted Q-6 alkoxy, optionally substituted Ci-6 alkylthio, optionally substituted Ci-6 alkylsulfinyl, optionally substituted Ci-6 alkylsulfonyl, cyano, nitro, formyl, RnON=C(R12), optionally substituted Q-6 alkylcarbonyl, optionally substituted Ci-6 alkoxycarbonyl or SF5;
1 9 or R and R together with the atoms to which they are attached may be joined to form a five, six or seven-membered saturated or unsaturated ring carbocylic or heterocyclic ring which may contain one or two heteroatoms selected from O, N or S and which may be optionally substituted by -6 alkyl, Q-6 haloalkyl or halogen;
R9 is hydrogen, cyano, nitro, optionally substituted Q-6 alkyl, optionally substituted C3-7 cycloalkyl, optionally substituted (C2-6)alkenyl(Q-6)alkyl, optionally substituted (C2-6)alkynyl(Q-6)alkyl, optionally substituted phenyl, optionally substituted heteroaryl, optionally substituted Ci-6 alkylcarbonyl, optionally substituted Ci-6 alkoxycarbonyl, optionally substituted Ci-6 alkylamino, optionally substituted di(Q-6)alkylamino, optionally substituted Ci-6 alkylcarbonylamino, optionally substituted Q-6 alkoxycarbonylamino, optionally substituted Ci-6 alkoxy, optionally substituted Q- alkylthio, optionally substituted Q-6 alkylsulfinyl, optionally substituted Q-6 alkylsulfonyl, optionally substituted arylthio, optionally substituted arylsulfinyl, optionally substituted arylsulfonyl or Q-6 acyloxy;
R10 is hydrogen, cyano, optionally substituted Q-8 alkyl, optionally substituted [C2-6 alkenyl(Ci-6)alkylJ. optionally substituted [C2-6 alkynyl(Q-6)alkyl], optionally substituted C3-7 cycloalkyl, optionally substituted [C3-7 cycloalkyl(Q-6)alkyl], Q-6 alkoxy(Q-6)alkyl, optionally substituted Q-6 alkoxycarbonyl, optionally substituted Ci-6 alkylcarbonyl, optionally substituted Q-6 alkylaminocarbonyl, optionally substituted di(Q-6)alkylaminocarbonyl, optionally substituted phenyl, optionally substituted heteroaryl, optionally substituted alkylsulfonyl or optionally substituted arylsulfonyl; R8 is hydrogen, halogen, nitro, cyano, optionally substituted Q.8 alkyl, optionally substituted C2-6 alkenyl, optionally substituted -6 alkynyl, optionally substituted C3.7 cycloalkyl, optionally substituted Ci-6 alkoxycarbonyl, optionally substituted Ci-6 alkylcarbonyl, optionally substituted Ci-6 alkylaminocarbonyl, optionally substituted di(Ci-6)alkylaminocarbonyl, optionally substituted phenyl or optionally substituted heteroaryl;
R13 and R14 are, independently, optionally substituted Ci-6 alkyl or R13 and R14 together with the N atom to which they are attached form a five, six or seven-membered heterocyclic ring which may contain one or two further heteroatoms selected from O, N or S and which may be optionally substituted by one or two Q-6 alkyl groups;
R15 is hydrogen, optionally substituted Ci.20 alkyl, optionally substituted [C2-2o alkenyl(Ci-6)alkyl], optionally substituted [C2-20 alkynyl(Q-6)alkyl], optionally substituted C3-7 cycloalkyl, optionally substituted aryl, optionally substituted heteroaryl, optionally substituted [heterocyclyl(Q-6)alkylCH=N] or di(Q-6)alkylC=N; R16 and R17 are, independently, hydrogen, optionally substituted Q-2o alkyl, optionally substituted C3-7 cycloalkyl, optionally substituted [C2-20 alkenyl(Q-6)alkyl]. optionally substituted [C2-2o alkynyl(Q-6)alkyl], optionally substituted Ci-20 alkoxycarbonyl, optionally substituted phenoxycarbonyl, formyl, optionally substituted Q-2o alkylcarbonyl, optionally substituted Ci-20 alkylsulfonyl or optionally substituted phenylsulfonyl; or R16 and R17 together with the N atom to which they are attached form a five, six or seven-membered heterocyclic ring which may contain one or two further heteroatoms selected from O, N or S and which may be optionally substituted by one or two Q-6 alkyl groups;
R18 and R11 are, independently, hydrogen, optionally substituted phenyl (Q_2)alkyl or optionally substituted Q-2o alkyl; and R19 and R12 are independently hydrogen, optionally substituted phenyl or optionally substituted Ci-6 alkyl.
When present, optional substituents on alkylene, alkenylene or alkynylene moieties include (subject to valency constraints) one or more of hydroxy, halogen, Q-6 alkyl, Q-6 haloalkyl, Q-6 cyanoalkyl, Q-6 alkoxy(Q-6) alkyl, Q-6 alkoxy, cyano, =O, =NR20 and =CR21R22; and, especially, one or more of halogen, Ci-6 alkyl, Ci-6 haloalkyl, Q-6 cyanoalkyl, Q-6 alkoxy(Q-6) alkyl, Q-6 alkoxy, cyano, =O, =NR20 and =CR21R22; wherein R20 is Q-6 alkyl, Q-6 haloalkyl, OR23 or NR24R25; where R21 and R22 are, independently, hydrogen, Q-6 alkyl, Q-6 alkoxy, Q-6 haloalkyl, cyano, Q-6 alkoxycarbonyl, Q-6 alkylcarbonyl or NR26R27; R23 is Q-6 alkyl, Q-6 haloalkyl or phenyl(Q-2)alkyl; R24 and R25 are, independently, hydrogen, Q-8 alkyl, C3- cycloalkyl, C2-6 alkenyl(C1-6)alkyl, C2-β alkynyl(Q-6)alkyl, C2.6 haloalkyl, Q-6 alkoxy(Ci-6)alkyl, Ci-6 alkoxycarbonyl(Ci-6)alkyl, carboxy(Q-6)alkyl or phenyl(Cι-2)alkyl; or R24 and R25 together with the N atom to which they are attached form a five, six or seven-membered heterocyclic ring which may contain one or two further hetero atoms selected from O, N or S and which is optionally substituted by one or two Q-6 alkyl groups; R26 and R27 are, independently, hydrogen, Q-8 alkyl, C3- cycloalkyl, C2-6 alkenyl(Q-6)alkyl, C2-6 alkynyl(Q-6)alkyl, C2-6 haloalkyl, Q-6 alkoxy(Q- 6)alkyl, Ci-6 alkoxycarbonyl(Q-6)alkyl, carboxy(Q-6)alkyl or phenyl(Cι-2)alkyl; or R26 and R27 together with the N atom to which they are attached form a five, six or seven-membered heterocyclic ring which may contain one or two further heteroatoms selected from O, N or S and which is optionally substituted by one or two Ci-6 alkyl groups.
Each alkyl moiety is a straight or branched chain and is, for example, methyl, ethyl, n-propyl, ra-butyl, n-pentyl, n-hexyl, wo-propyl, n-butyl, -fee-butyl, wo-butyl, tert-butyl or neo-pentyl.
When present, the optional substituents on an alkyl moiety include one or more of halogen, nitro, cyano, NCS-, C3-7 cycloalkyl (itself optionally substituted with Ci-6 alkyl or halogen), C5- cycloalkenyl (itself optionally substituted with Q-6 alkyl or halogen), hydroxy, Q-io alkoxy, Q_io alkoxy(Q-ιo)alkoxy, tri(Q-4)alkylsilyl(Q-6)alkoxy, Ci-6 alkoxycarbonyl(Q-ιo)alkoxy, Q.i0 haloalkoxy, aryl(Q. )alkoxy (where the aryl group is optionally substituted), C3.7 cycloalkyloxy (where the cycloalkyl group is optionally substituted with Q-e alkyl or halogen), Q-io alkenyloxy, Q-io alkynyloxy, SH, Q-io alkylthio, Q.io haloalkylthio, aryl(Q-4)alkylthio (where the aryl group is optionally substituted), C3- cycloalkylthio (where the cycloalkyl group is optionally substituted with Q-6 alkyl or halogen), tti(Q-4)alkylsilyl(Q-6)alkylthio, arylthio (where the aryl group is optionally substituted), Q-6 alkylsulfonyl, Q-6 haloalkylsulfonyl, Q-6 alkylsulfinyl, Ci-6 haloalkylsulfinyl, arylsulfonyl (where the aryl group may be further optionally substituted), tri(Q-4)alkylsilyl, aryldi(Q- )alkylsilyl, (Q-4)alkyldiarylsilyl, triarylsilyl, Q-io alkylcarbonyl, HO2C, Q-10 alkoxycarbonyl, aminocarbonyl, Q-6 alkylaminocarbonyl, di(Q-6 alkylaminocarbonyl, N-(Q-3 alkyl)-N-(Ci-3 alkoxy)aminocarbonyl, Ci-6 alkylcarbonyloxy, arylcarbonyloxy (where the aryl group is optionally substituted), di(Q-6)alkylaminocarbonyloxy, aryl (itself optionally substituted), heteroaryl (itself optionally substituted), heterocyclyl (itself optionally substituted with Q-6 alkyl or halogen), aryloxy (where the aryl group is optionally substituted), heteroaryloxy, (where the heteroaryl group is optionally substituted), heterocyclyloxy (where the heterocyclyl group is optionally substituted with Ci-6 alkyl or halogen), amino, Q-6 alkylamino, di(Q-6)alkylamino, Q-6 alkylcarbonylamino and N-(C1-6)alkylcarbonyl-N-(Q-6)alkylamino. Alkenyl and alkynyl moieties can be in the form of straight or branched chains, and the alkenyl moieties, where appropriate, can be of either the (E or ©-configuration. Examples are vinyl, allyl and propargyl.
When present, the optional substituents on alkenyl or alkynyl include those optional substituents given above for an alkyl moiety. In the context of this specification acyl is optionally substituted Q-6 alkylcarbonyl (for example acetyl), optionally substituted C2-6 alkenylcarbonyl, optionally substituted C2-6 alkynylcarbonyl, optionally substituted arylcarbonyl (for example benzoyl) or optionally substituted heteroarylcarbonyl.
Halogen is fluorine, chlorine, bromine or iodine. Haloalkyl groups are alkyl groups which are substituted with one or more of the same or different halogen atoms and are, for example, CF3, CF2C1, CF3CH2 or CHF2CH2.
Haloalkenyl groups are alkenyl groups which are substituted with one or more of the same or different halogen atoms.
Aryl includes naphthyl, anthracyl, fluorenyl and indenyl but is preferably phenyl. The term heteroaryl refers to an aromatic ring containing up to 10 atoms including one or more heteroatoms (preferably one or two heteroatoms) selected from O, S and N. Examples of such rings include pyridine, pyrimidine, furan, quinoline, quinazoline, pyrazole, thiophene, thiazole, oxazole and isoxazole.
The terms heterocycle and heterocyclyl refer to a non-aromatic ring containing up to 10 atoms including one or more (preferably one or two) heteroatoms selected from O, S and N. Examples of such rings include 1,3-dioxolane, tetrahydrofuran and morpholine.
When present, the optional substituents on heterocyclyl include Q-6 alkyl as well a those optional substituents given above for an alkyl moiety.
Cycloalkyl includes cyclopropyl, cyclopentyl and cyclohexyl. Cycloalkenyl includes cyclopentenyl and cyclohexenyl.
When present, the optional substituents on cycloalkyl or cycloalkenyl include Q-3 alkyl as well as those optional substituents given above for an alkyl moiety. Carbocyclic rings include aryl, cycloalkyl and cycloalkenyl groups. When present, the optional substituents on aryl or heteroaryl are selected, independently, from halogen, nitro, cyano, NCS-, Q-6 alkyl, Q-6 haloalkyl, Ci-6 alkoxy(Q-6)alkyl, C2-6 alkenyl, C2-6 haloalkenyl, -6 alkynyl, C3.7 cycloalkyl (itself optionally substituted with -6 alkyl or halogen), Q- cycloalkenyl (itself optionally substituted with Q-6 alkyl or halogen), hydroxy, Q-jo alkoxy, Q-io alkoxy(Q-ιo)alkoxy, tri(Q- )alkylsilyl(Q-6)alkoxy, Q-6 alkoxycarbonyl(Ci-io)alkoxy, CMO haloalkoxy, aryl(Ci- )alkoxy (where the aryl group is optionally substituted), C3-7 cycloalkyloxy (where the cycloalkyl group is optionally substituted with Ci-6 alkyl or halogen), Q-10 alkenyloxy, Q_ιo alkynyloxy, SH, Q-io alkylthio, Cι-ιo haloalkylthio, aryl(Q-4)alkylthio (where the aryl group may be further optionally substituted), C3- cycloalkylthio (where the cycloalkyl group is optionally substituted with Q-e alkyl or halogen), tei(Q.4)alkylsilyl(Q-6)alkylthio, arylthio (where the aryl group is optionally substituted), Q-6 alkylsulfonyl, Q.6 haloalkylsulfonyl, Ci-6 alkylsulfinyl, Q-6 haloalkylsulfinyl, arylsulfonyl (where the aryl group is optionally substituted), tri(Cι_4)a--kylsiryl, aryld Q-^alkylsilyl, (Q-4)alkyldiarylsilyl, triarylsilyl, Cno alkylcarbonyl, HO2C, Cι-ιo alkoxycarbonyl, aminocarbonyl, Q-6 alkylaminocarbonyl, di(Q-6 alkylaminocarbonyl, N-(Q,3 alkyl)-N-(Ci-3 alkoxy)aminocarbonyl, Ci-6 alkylcarbonyloxy, arylcarbonyloxy (where the aryl group is optionally substituted), di(Q-6)alkylaminocarbonyloxy, aryl (itself optionally substituted), heteroaryl (which itself may be further optionally substituted), heterocyclyl (itself optionally substituted with Ci-6 alkyl or halogen), aryloxy (where the aryl group is optionally substituted), heteroaryloxy (where the heteroaryl group is optionally substituted), heterocyclyloxy (where the heterocyclyl group is optionally substituted with Q-6 alkyl or halogen), amino, Q-6 alkylamino, cϋ(Q-6)a-kylamino, Q-6 alkylcarbonylamino and N-(Q-6)alkylcarbonyl-N-(Q.6)alkyl-unino. For substituted phenyl moieties, heterocyclyl and heteroaryl groups it is preferred that one or more substituents are independently selected from halogen, Q,6 alkyl, Ci-6 haloalkyl, Ci-6 alkoxy(Q-6)alkyl, Q-6 alkoxy, Ci-6 haloalkoxy, Ci-6 alkylthio, Q-6 haloalkylthio, Q-6 alkylsulfinyl, Q-6 haloalkylsulfinyl, Q-6 alkylsulfonyl, Q-6 haloalkylsulfonyl, -6 alkenyl, C2-6 haloalkenyl, C2-6 alkynyl, Q-7 cycloalkyl, nitro, cyano, CO2H, Q-6 alkylcarbonyl, Q-6 alkoxycarbonyl, R28R29N or R30R31NC(O); wherein R28, R29, R30 and R31 are, independently, hydrogen or Q-6 alkyl.
It is to be understood that dialkylamino substituents include those where the dialkyl groups together with the N atom to which they are attached form a five, six or seven- membered heterocyclic ring which may contain one or two further heteroatoms selected from O, N or S and which is optionally substituted by one or two independently selected (Q-6)alkyl groups. When heterocyclic rings are formed by joining two groups on an N atom, the resulting rings are suitably pyrrolidine, piperidine, thiomorpholine and morpholine each of which may be substituted by one or two independently selected (Ci-6) alkyl groups. Phenyl(Q--t.)alkyl is, for example, 1-phenyleth-l-yl, 2-phenyleth-l-yl, 2-phenylprop-2-yl, 3-phenylprop-l-yl, but is preferably benzyl. Analogous terms are to be interpreted in corresponding fashion.
Preferably the optional substituents on an alkyl moiety include one or more of halogen, nitro, cyano, HO2 Ci-10 alkoxy (itself optionally substituted by Q-io alkoxy), aryl(Q-4)alkoxy, Q-10 alkylthio, Q-10 alkylcarbonyl, Q-io alkoxycarbonyl, Ci-6 alkylaminocarbonyl, di(Q-6 alkylaminocarbonyl, (Q-6)alkylcarbonyloxy, optionally substituted phenyl, heteroaryl, aryloxy, arylcarbonyloxy, heteroaryloxy, heterocyclyl, heterocyclyloxy, C3-7 cycloalkyl (itself optionally substituted with (Q-6)alkyl or halogen), C3-7 cycloalkyloxy, Q-7 cycloalkenyl, Q-e alkylsulfonyl, Q-6 alkylsulfinyl, tri(Q-
4)alkylsilyl, tri(Q- )alkylsilyl(Q-6)alkoxy, aryldi(Q-4)alkylsilyl, (Q-^alkyldiarylsilyl and triarylsilyl.
Preferably the optional substituents on alkenyl or alkynyl include one or more of halogen, aryl and C3-7 cycloalkyl. It is more preferred that heterocyclyl is optionally substituted by Q-6 alkyl.
Preferably the optional substituents for cycloalkyl include halogen, cyano and Q-3 alkyl.
Preferably the optional substituents for cycloalkenyl include Q.3 alkyl, halogen and cyano. The method of the present invention preferably produces a compound of formula
CIA):
Figure imgf000013_0001
wherein A, B, Z, R1, R2 , R3, R4, R5, R6 and R7 are as defined above for a compound of formula (I). More preferred compounds of formula (LA) are those wherein: R1 is hydrogen, halogen, Q-6 alkyl, Q-6 alkenyl, -6 alkynyl, Q-6 cyanoalkyl, Q-6 haloalkyl, Q-6 alkoxy, Q-6 haloalkoxy, Ci-6 alkylthio, Ci-6 haloalkylthio, C3-6 cycloalkyl, C3- 7 cycloalkyl(Q-4)alkyl, Q-6 alkoxy(Q-6)alkyl, cyano, nitro or SF5; A is Ci-6 alkylene, Q-6 alkenylene , Ci-6 alkylenoxy, oxy(Q-6)alkylene, Ci-6 alkylenamino or Ci-6 alkylenethio, each of which is optionally substituted by Q-3 alkyl, Q-3 haloalkyl, Q-3 cyanoalkyl, halogen, Q-3 alkoxy, Q-6 alkoxycarbonyl, cyano, =O, =NR20 or =CR21R22; B is N or CR8; Z is O, S or NR10; R is hydrogen, Q.io alkyl, benzyloxymethyl, benzoyloxymethyl, Ci-6alkoxy(Q-6) alkyl, C2.6 alkenyl(Cι-6)alkyl (especially allyl), C2-6 alkynyl(Cι-6)alkyl (especially propargyl), Q-io alkylcarbonyl or Ci-io alkoxycarbonyl (especially wobutoxycarbonyl); R4, R5 and R6 are independently selected from hydrogen, halogen, Q-6 alkyl, Ci-6 alkoxy, Q-6 haloalkoxy, Ci-6 alkylthio, Ci-6 haloalkylthio, Q-6 alkylsulfinyl, Q_6 haloalkylsulfinyl, Ci-6 alkylsulfonyl, Q-e haloalkylsulfonyl, Q-6 haloalkyl, cyano, nitro, Q-6 alkylcarbonyl, Q-6 alkoxycarbonyl or SF5;
R7 is cyano, Q-8 alkyl, Q-8 haloalkyl, Cι-8 cyanoalkyl, C2-6 alkenyl, C2-6 alkynyl, C3-7 cycloalkyl, C3.7 halocycloalkyl, C3-7 cyanocycloalkyl, Q-3 alkyl(C3-7)cycloalkyl, Q-3 alkyl(C3.7)halocycloalkyl, C5-6 cycloalkenyl, C3-7 cycloalkyl(Cι-6)alkyl, C5-6 cycloalkenyl (Q-6)alkyl, C2-6 haloalkenyl, Ci-6 cyanoalkenyl, Ci-6 alkoxy(Ci-6)alkyl, C3-e alkenyloxy
(Q-6)alkyl, C3-6 alkynyloxy(Cι-6)alkyl, aryloxy(Q-6)alkyl, formyl, Q-6 carboxyalkyl, Ci-6 alkylcarbonyl(Cι-6)alkyl, C2-e alkenylcarbonyl(Q-6)alkyl, C2-6 alkynylcarbonyl(Ci- 6)alkyl, Ci-6 alkoxycarbonyl(Q-6)alkyl, C3-6 alkenyloxycarbonyl(Q-6)alkyl, C3-6 alkynyloxycarbonyl(Q-6)alkyl, aryloxycarbonyl(Q-6)alkyl, Ci-6 alkylthio(Cι-6)alkyl, Ci-6 alkylsulfinyl(Q-6)alkyl, Cι-6 alkylsulfonyl(Ci-6)alkyl, aminocarbonyl(Cι-6)alkyl, aminocarbonyl(C2-6)alkenyl, aminocarbonyl(C2-6)alkynyl, Ci-6 alkylaminocarbonyl(Cι-6) alkyl, di(Cι-6)alkylaminocarbonyl(Ci-6)alkyl, Q-6 alkylaminocarbonyl(C1-6)alkenyl, di(Ci-6)alkylaminocarbonyl(Q-6)alkenyl, alkylaminocarbonyl(Cι-6)alkynyl, di(Ci-6)alkylaminocarbonyl(Ci-6)alkynyl, Ci-6 alkoxycarbonyl, Ci-6 alkylcarbonyl, aminocarbonyl, Q-6 alkylaminocarbonyl, di(Ci-6)alkylaminocarbonyl, phenyl (optionally substituted by halo, nitro, cyano, Q-6 alkyl, Q-6 haloalkyl, Q-6 alkoxy or Q-6 haloalkoxy), phenyl(Q-4)alkyl (wherein the phenyl group is optionally substituted by halo, nitro, cyano, Ci-6 alkyl, Ci-6 haloalkyl, Q-6 alkoxy or Q-6 haloalkoxy), phenyl(C2-4)alkenyl, (wherein the phenyl group is optionally substituted by halo, nitro, cyano, Ci-6 alkyl, Q-6 haloalkyl, Q-6 alkoxy or Q-6 haloalkoxy), heteroaryl (optionally substituted by halo, nitro, cyano, Q-6 alkyl, Q-6 haloalkyl, Ci-6 alkoxy or Q-6 haloalkoxy), heterocyclyl (optionally substituted by halo, nitro, cyano, Q-6 alkyl, Q-β haloalkyl, Ci-6 alkoxy or Ci-6 haloalkoxy), heteroaryl(Q- ) alkyl (where the heteroaryl may be substituted by halo, nitro, cyano, Q-6 alkyl, Ci-6 haloalkyl, Q-6 alkoxy or Ci-6 haloalkoxy), heterocyclyl(Q- )alkyl (where the heterocyclyl may be substituted by halo, cyano, Ci-6 alkyl, Q-6 haloalkyl, Ci-6 alkoxy or Q-6 haloalkoxy), R15O, Q-8 alkylthio, R16R17N or R18ON=C(R19);
R is hydrogen, halogen, Ci-6 alkyl, -6 alkenyl, Q-6 alkynyl, Q-6 haloalkyl, Q-6 alkoxy, Q-6 alkoxy (Q.6)alkyl, Q-6 haloalkoxy, Q-6 alkylthio, Ci-6 haloalkylthio, Q-6 alkylsulfinyl, Q-6 haloalkylsulfinyl, Q-6 alkylsulfonyl, Q-6 haloalkylsulfonyl, Ci-6 haloalkyl, cyano, nitro, formyl, CH=NORπ, Q-6 alkylcarbonyl, Q-6 alkoxycarbonyl or SF5; or together R1 and R2 together with the atoms to which they are attached may be joined to form a five, six or seven-membered saturated or unsaturated ring carbocylic or heterocyclic ring which may contain one or two hetero atoms selected from O, N or S and which may be optionally substituted by Q-6 alkyl, Q-6 haloalkyl or halogen;
R9 is cyano, nitro, Ci-6 alkyl, Q-6 haloalkyl, Q-7 cycloalkyl, C3-7 cycloalkyl(Q- e)alkyl,
CH2- (C2-6) alkenyl, CH2(C2-6)alkynyl, phenyl (optionally substituted by halo, nitro, cyano, Ci-6 alkyl, Q-6 haloalkyl, Ci-6 alkoxy or Ci-6 haloalkoxy) heteroaryl (optionally substituted by halo, nitro, cyano, Q-e alkyl, Ci-6 haloalkyl, -6 alkoxy or Q-6 haloalkoxy), Q-6 alkylcarbonyl, Ci-6 alkoxycarbonyl, Q-6 alkylamino, di(Q-6)alkylamino, Ci-6 alkylcarbonylamino, Q-6 alkoxycarbonylamino, Q-6 alkoxy, Ci-6 alkylthio, Ci-6 alkylsulfinyl, Ci-6 alkylsulfonyl, Q-6 haloalkylthio, -6 haloalkylsulfinyl, Q-6 haloalkylsulfonyl, arylthio, arylsulfinyl, arylsulfonyl or OCO(Q-6)alkyl;
R10 is hydrogen, Q-8 alkyl, Q-6 haloalkyl, Q.6 cyanoalkyl, Q-6 alkenyl, Q-6 alkynyl, Q-7 cycloalkyl, Q-6 haloalkenyl, Q_7 cycloalkyl(Q-6)alkyl, Ci-6 alkoxy(Q-6)alkyl, Q-6 alkoxycarbonyl, Ci-6 alkylcarbonyl, Ci-6 alkylaminocarbonyl, di(Q-6)alkylaminocarbonyl, phenyl (optionally substituted by halo, nitro, cyano, Q-6 alkyl, Q-6 haloalkyl, Q-6 alkoxy or Ci-6 haloalkoxy) or heteroaryl (optionally substituted by halo, nitro, cyano, Ci-6 alkyl, Ci-6 haloalkyl, Ci-6 alkoxy or Q-6 haloalkoxy); R20 is Q-6 alkyl, OR23 or NR24R25; R21 is hydrogen, Q-6 alkyl or Q-6 haloalkyl; R22 is hydrogen, Ci-6 alkyl, Q-6 haloalkyl, Q-6 alkoxy, cyano, Q-6 alkoxycarbonyl, Q-6 alkylcarbonyl orNR26R27;
R8 is hydrogen, halogen, nitro, cyano, Q-8 alkyl, Ci-6 haloalkyl, Ci-6 cyanoalkyl, -6 alkenyl, Q-6 alkynyl, Q-7 cycloalkyl, C2-6 haloalkenyl, Q-7 cycloalkyl(Q-6)alkyl, Ci-6 alkoxy(Q.6)alkyl, Ci-6 alkoxycarbonyl, Q-6 alkylcarbonyl, Ci-6 alkylaminocarbonyl, di(Q-6) alkylaminocarbonyl, Ci-6 alkoxycarbonyl(Cι-6)alkyl, Ci-6 alkylcarbonyl(Q-6)alkyl, Ci-6 alkylaminocarbonyl(Ci-6)alkyl, di(Ci-6)alkylaminocarbonyl(Q-6)alkyl, phenyl (optionally substituted by halo, nitro, cyano, Q-6 alkyl, Q-6 haloalkyl, Ci-6 alkoxy or Ci-6 haloalkoxy), phenyl(Q-6)alkyl (wherein the phenyl group is optionally substituted by halo, nitro, cyano, Ci-6 alkyl, Q-6 haloalkyl, Q-6 alkoxy or Q-6 haloalkoxy), heteroaryl (optionally substituted by halo, nitro, cyano, Q-6 alkyl, Q-6 haloalkyl, Q-6 alkoxy or Q-6 haloalkoxy) or heteroaryl(Q-6)alkyl (wherein the heteroaryl group is optionally substituted by halo, nitro, cyano, Q-6 alkyl, Q-e haloalkyl, Ci-6 alkoxy or Q-6 haloalkoxy);
R23 is Q-e alkyl or optionally substituted phenyl(Ci-2)alkyl; R24 and R25 are, independently, hydrogen, Q-8 alkyl or phenyl (optionally substituted by halo, nitro, cyano, Q-6 alkyl, Q-6 haloalkyl, -6 alkoxy or Ci-6 haloalkoxy);
R15 is hydrogen, Q-8 alkyl, Q-6 haloalkyl, Q-6 cyanoalkyl, -6 alkenyl, -6 alkynyl, Q-6 alkoxy(Q-6)alkyl, phenyl(Q--ι)alkyl (wherein the phenyl group is optionally substituted by halo, nitro, cyano, Q-6 alkyl, Q-6 haloalkyl, Q-6 alkoxy or Q-6 haloalkoxy), heteroaryl(Q--t)alkyl (wherein the heteroaryl group is optionally substituted by halo, nitro, cyano, Q-6 alkyl, Q-6 haloalkyl, Q-6 alkoxy or Q-6 haloalkoxy), heterocyclyl (optionally substituted by halo, nitro, cyano, Q-6 alkyl, Q-6 haloalkyl, Q-6 alkoxy or Ci-6 haloalkoxy), heterocyclyl(Q-4)alkyl (wherein the heterocyclyl group is optionally substituted by halo, nitro, cyano, Q_6 alkyl, Q-6 haloalkyl, Q-6 alkoxy or Q-6 haloalkoxy), Q-6 alkoxycarbonyl(Q-6)alkyl or N=C(CH3)2;
R19 is Ci-6 alkyl, Q-e haloalkyl or phenyl (optionally substituted by halo, nitro, cyano, Ci-6 alkyl, Q-6 haloalkyl, Ci-6 alkoxy or Q-6 haloalkoxy);
R16 and R17 are, independently, hydrogen, Q-8 alkyl, -7 cycloalkyl, -6 alkenyl, -6 alkynyl, Q-7 cycloalkyl(Q-4)alkyl, Q-β haloalkyl, Q-6 alkoxy(Q-6)alkyl, Q-6 alkoxycarbonyl, or R16 and R17 together with the N atom to which they are attached form a five, six or seven-membered heterocyclic ring which may contain one or two further hetero atoms selected from O, N or S and which may be optionally substituted by one or two Ci-6 alkyl groups; R18 and R11 are, independently, Ci-6 alkyl or phenyl(Q-2)alkyl (wherein the phenyl group is optionally substituted by halo, nitro, cyano, Ci-6 alkyl, Q-6 haloalkyl, Q-6 alkoxy or Ci-6 haloalkoxy); and
R26 and R27 are, independently, hydrogen, Q-8 alkyl, Q-7 cycloalkyl, -6 alkenyl, -6 alkynyl, -6 haloalkyl, Q-6 alkoxy(Q-6)alkyl, Q-6 alkoxycarbonyl(Q-6)alkyl, carboxy(Q-6)alkyl or phenyl(Q-2)alkyl; or R26 and R27 together with the N atom to which they are attached form a five, six or seven-membered heterocyclic ring which may contain one or two further heteroatoms selected from O, N or S and which may be optionally substituted by one or two Ci-6 alkyl groups. It is preferred that A is Q-6 alkylene, Q-6 alkenylene, Ci-6 alkylenoxy, oxy(Q-6)alkylene or Ci-6 alkylenamino, each of which is optionally substituted by Q-3 alkyl, Q-3 haloalkyl, Q-3 cyanoalkyl, halogen, Q-3 alkoxy, Ci-6 alkoxycarbonyl, cyano, =O, =NR20 or =CR21R22; where R20 is Q-6 alkyl, OR23 or NR24R25; R23 is Q-6 alkyl or phenyl(Q-2)alkyl (where the phenyl group is optionally substituted by halo, nitro, cyano, Q-6 alkyl, Ci-6 haloalkyl, Q-6 alkoxy or Ci-6 haloalkoxy); R24 and R25 are, independently, hydrogen, Q-8 alkyl or phenyl (which may be optionally substituted by halo, nitro, cyano, Ci-6 alkyl, Q-6 haloalkyl, Ci-6 alkoxy or Q-6 haloalkoxy); R21 is hydrogen, Q.6 alkyl or Q-6 haloalkyl; R22 is hydrogen, Ci-6 alkyl, Ci-6 haloalkyl, Q_6 alkoxy, cyano, Ci-6 alkoxycarbonyl, Q-6 alkylcarbonyl or NR26R27; and R26 and R27 are, independently, hydrogen, Q-8 alkyl, Q-7 cycloalkyl, -6 alkenyl, -6 alkynyl, Q-β haloalkyl, Q-6 alkoxy(Q-6)alkyl, Q-6 alkoxycarbonyl(Q-6)alkyl, carboxy(Q-6)alkyl or phenyl(Q-2)alkyl; or R26 and R27 together with the N atom to which they are attached form a five, six or seven-membered heterocyclic ring which may contain one or two further heteroatoms selected from O, N or S and which may be optionally substituted by one or two Q-6 alkyl groups. A is more preferably Q^ alkylene (optionally substituted by halogen, Q-3 alkyl or
Q-3 alkoxy, -C(O)- or Q-4 alkyleneoxy (which may be optionally substituted by Q-3 alkyl).
It is even more preferred that A is Q-2 alkyl-substituted Q-4 alkylene, fluoro- substituted Q-4 alkylene, methoxy-substituted Q-4 alkylene, -C(O)- or Q-4 alkyleneoxy; still more preferably A is Q-2 alkyl-substituted Q- alkylene, fluoro-substituted CM alkylene or methoxy-substituted Q- alkylene.
It is further preferred that A is CH(CH3)CH2, CH2CH(CH3), CH(CH3), CHF, CH(OCH3) or CH(CH3)O; yet further preferred is for A to be CH(CH3)CH2, CH2CH(CH3), CH(CH3), CHF or CH(CH3)O; it is especially preferred that A is CHF, CH(OCH3) or CH(CH3); and most preferably A is CHF or CH(CH3).
B is preferably N.
Z is preferably O or S, more preferably O. It is preferred that R1 is hydrogen, halogen, Ci-6 alkyl, Q-6 cyanoalkyl, Ci-6 haloalkyl, -7 cycloalkyl(Q- )alkyl, Q-6 alkoxy(Q-6)alkyl, Q-6 alkenyl, Q-6 alkynyl, Q-6 alkoxy, Q-6 haloalkoxy, Ci-6 alkylthio, Ci-6 haloalkylthio, Q-6 cycloalkyl, cyano, nitro or SF5.
R1 is more preferably hydrogen, halogen, Q-6 alkyl, C2-6 alkenyl, Ci-6 haloalkyl, Q-6 alkoxy, Ci-6 haloalkoxy, Q-6 alkylthio, Q-6 haloalkylthio, C3-6 cycloalkyl, cyano, nitro or SF5.
It is even more preferred that R1 is hydrogen, halogen, Ci-6 alkyl, Q-6 haloalkyl, Q-6 alkoxy(Q-6)alkyl, -6 alkenyl, Q-6 alkoxy, Q-6 haloalkoxy, Q-6 alkylthio, Ci-6 haloalkylthio, -6 cycloalkyl or cyano.
It is most preferred that R1 is halogen, Q-6 alkyl, Q-6 haloalkyl, Ci-6 alkoxy or Ci-6 haloalkoxy.
It is preferred that R2 is hydrogen, halogen, Ci-6 alkyl, Ci-6 haloalkyl, Ci-6 alkoxy(Q-6)alkyl, -6 alkenyl, Q-6 alkynyl, Q-6 alkoxy, Q-6 haloalkoxy, Q-6 alkylthio, Ci-6 haloalkylthio, Ci-6 alkylsulfinyl, Q-6 haloalkylsulfinyl, Ci-6 alkylsulfonyl, Ci-6 haloalkylsulfonyl, cyano, nitro, formyl, Ci-6 alkylcarbonyl, Q-6 alkoxycarbonyl or CH=NORπ; or that R1 and R2 together with the atoms to which they are attached may be joined to form a five, six or seven-membered saturated or unsaturated, carbocylic or heterocyclic ring which may contain one or two heteroatoms selected from O, N or S and which is optionally substituted by Q-6 alkyl, Q-6 haloalkyl or halogen; where R11 is phenyl(Q-2)alkyl (wherein the phenyl group is optionally substituted by halo, nitro, cyano, Q-6 alkyl, Q-6 haloalkyl, Ci-6 alkoxy or Ci-6 haloalkoxy) or Q-6 alkyl.
It is more preferred that R2 is hydrogen, halogen, Q-6 alkyl, Q-6 haloalkyl, Q-6 alkoxy (Q-6)alkyl, Q-6 alkoxy, Q-6 haloalkoxy, Ci-6 alkylthio or SF5; or R1 and R2 together with the atoms to which they are attached form a cyclopentane or benzene ring optionally substituted by Ci-6 alkyl, Q-6 haloalkyl or halogen. R2 is even more preferably hydrogen, halogen, Ci-6 alkyl, Q-6 haloalkyl, Q-6 alkoxy,
Q-6 haloalkoxy, Q-6 alkoxy(Q-6)alkyl, Q-6 alkylthio or SF5; or R1 and R2 together with the atoms to which they are attached form a benzene ring optionally substituted by Q-6 alkyl, Q-6 haloalkyl or halogen. It is further preferred that R2 is hydrogen, halogen, Ci-6 alkyl, Q-6 haloalkyl, Q-6
1 alkoxy(Q-6)alkyl, Ci-6 alkoxy, Ci-6 haloalkoxy, or R and R together with the atoms to which they are attached form a cyclopentane ring optionally substituted by Q-6 alkyl, Q-6 haloalkyl or halogen. R2 is most preferably halogen, Ci-6 alkyl, Ci-6 haloalkyl, Q-6 alkoxy, Q-6 alkoxy (Q-6)alkyl or Ci-6 haloalkoxy.
It is preferred that R3 is hydrogen, Q-10 alkyl, Ci-6 alkylcarbonyloxy(Q-6)alkyl, benzoyloxymethyl (where the phenyl ring is optionally substituted with halogen or CM alkyl), Q-6 alkoxy(Q-6)alkyl (where the alkyl group is optionally substituted by aryl or CM alkoxycarbonyl), Q-6 alkenyloxy(Q-4)alkyl, -6 alkynyloxy(Q-4)alkyl, benzyloxy(Q- )alkyl (where the phenyl ring is optionally substituted with halogen or Q-4 alkyl), Q-7 cycloalkyl(Q--t)alkyl, heteroaryl(Q-3)alkyl (where the heteroaryl group is optionally substituted with halogen), tri(C1-4)alkylsilyl(C1-6)alkyl, Q-6 alkenyl(Q-6)alkyl (especially allyl), Q-6 haloalkenyl(Q-6)alkyl, CM alkoxycarbonyl(C2-6)alkenyl(Q-6)alkyl, Q-6 alkynyl(Q-6)alkyl, tri(Q- )aιkylsilyl(Q-6)alkynyl(Q-6)alkyl or Q-10 alkylcarbonyl.
It is further preferred that R3 is hydrogen, Ci-6 alkyl, Q-6 alkylcarbonyloxymethyl, benzoyloxymethyl (where the phenyl ring is optionally substituted with halogen or CM alkyl), Ci-6 alkoxymethyl, -6 alkenyloxymethyl, Q-6 alkynyloxymethyl, benzyloxymethyl (where the phenyl ring is optionally substituted with halogen or Q- alkyl), -6 alkynyl(Q-6)alkyl (especially propargyl) or Q_ιo alkylcarbonyl.
R3 is more preferably hydrogen, Q-6 alkyl, Ci-6 alkoxy(Q-6)alkyl, benzyloxymethyl or benzoyloxymethyl; or alternatively R3 may be Q-e alkylcarbonyloxymethyl.
It is most preferred that R3 is hydrogen, Q-6 alkyl, Q-6 alkylcarbonyloxymethyl or Q-6 alkoxymethyl. It is preferred that R4, R5 and R6 are, independently, hydrogen, halogen, Ci-6 alkyl,
Q-6 haloalkyl, Ci-6 alkoxy, Q-e haloalkoxy, Q-6 alkylthio, Ci-6 haloalkylthio, Q-6 alkylsulfinyl, Q_6 haloalkylsulfinyl, Q-6 alkylsulfonyl, Q-6 haloalkylsulfonyl, cyano, nitro, Q-6 alkylcarbonyl or Ci-6 alkoxycarbonyl.
It is more preferred that R4, R5 and R6 are, independently, hydrogen, halogen or Q-3 alkyl.
It is even more preferred that R4, R5 and R6 are, independently, hydrogen or halogen (especially fluorine). It is preferred that R7 is cyano, Q-8 alkyl, Q-8 haloalkyl, Q-8 cyanoalkyl, C3-7 cycloalkyl(Q-6)alkyl, C5-6 cycloalkenyl(Q-6)alkyl, Ci-6 alkoxy(Ci-6)alkyl, C3-6 alkenyloxy(Cι-6)alkyl, Q-6 alkynyloxy(Cι-6)alkyl, aryloxy(Ci-6)alkyl, Ci-6 carboxyalkyl, Q-6 alkylcarbonyl(Ci-6)alkyl, C2-6 alkenylcarbonyl(Cι-6)alkyl, C2-6 aιkynylcarbonyl(Q-6)alkyl, Q-6 alkoxycarbonyl(Cι-6)alkyl, C3-6 alkenyloxycarbonyl(Q-6)alkyl, C3-6 alkynyloxycarbonyl(Cι-6)alkyl, aryloxycarbonyl(Cι-6)alkyl, Ci-6 alkylthio(Q-6)alkyl, Ci-6 alkylsulfinyl(Q-6)alkyl, Ci-6 alkylsulfonyl(Cι-6)alkyl, aminocarbonyl(C1-6)alkyl, Ci-6 alkylarninocarbonyl(Ci-6)alkyl, di(Cι-6)alkylaminocarbonyl(Cι-6)alkyl, phenyl(Cι- )alkyl (wherein the phenyl group is optionally substituted by halo, nitro, cyano, Q-6 alkyl, Q.6 haloalkyl, Q-6 alkoxy or Q-6 haloalkoxy), heteroaryl(Q-4)alkyl (where the heteroaryl group is optionally substituted by halo, nitro, cyano, Q_6 alkyl, Ci-6 haloalkyl, Ci-6 alkoxy or Q-6 haloalkoxy), heterocyclyl(Q-4)alkyl (where the heterocyclyl group is optionally substituted by halo, cyano, Q-6 alkyl, Ci-6 haloalkyl, Q-6 alkoxy or Ci-e haloalkoxy), -6 alkenyl, Q-6 haloalkenyl, Q-6 cyanoalkenyl, -6 cycloalkenyl, aιmnocarbonyl(Q-6)alkenyl, Q-6 alkylarninocarbonyl(Q-6)alkenyl, άi(Q-6)alkylaminocarbonyl(Q-6)alkenyl, phenyl(Q-4)alkenyl (wherein the phenyl group is optionally substituted by halo, nitro, cyano, Q-6 alkyl, Q-6 haloalkyl, Ci-6 alkoxy or Q-6 haloalkoxy), Q-β alkynyl, aminocarbonyl(C2-6)alkynyl, alkylaminocarbonyl(Q-6)alkynyl, di(Cι-6)alkylaminocarbonyl(Cι-6)alkynyl, Q-7 cycloalkyl, -7 halocycloalkyl, Q-7 cyanocycloalkyl, Q-3 alkyl(Q-7)cycloalkyl, Q.3 alkyl(Q-7)halocycloalkyl, -6 cycloalkenyl, formyl, Ci-6 alkoxycarbonyl, Ci-6 alkylcarbonyl, aminocarbonyl, Ci-6 alkylaminocarbonyl, di(Q-6)alkylaminocarbonyl, phenyl (optionally substituted by halo, nitro, cyano, Ci-6 alkyl, Ci-6 haloalkyl, Ci-6 alkoxy or Q-6 haloalkoxy), heteroaryl (optionally substituted by halo, nitro, cyano, Ci-6 alkyl, Ci-6 haloalkyl, Q-6 alkoxy or Ci-6 haloalkoxy), heterocyclyl (optionally substituted by halo, nitro, cyano, Q-6 alkyl, Q-6 haloalkyl, Ci-6 alkoxy or Q-e haloalkoxy), Q.8 alkylthio, R15O, R16R17N or R18ON=C(R19); where R15 is hydrogen, Q-8 alkyl, Ci-6 haloalkyl, Ci-6 cyanoalkyl, Q-6 alkoxy(Q-6)alkyl, phenyl(Q--ι)alkyl, (wherein the phenyl group is optionally substituted by halo, nitro, cyano, Q-6 alkyl, Ci-6 haloalkyl, Q-6 alkoxy or Q-6 haloalkoxy), heteroaryl(Q-4)alkyl (wherein the heteroaryl group is optionally substituted by halo, nitro, cyano, Q-6 alkyl, Q-6 haloalkyl, Q-6 alkoxy or Q-6 haloalkoxy), heterocyclyl(Q_4)alkyl (wherein the heterocyclyl group is optionally substituted by halo, nitro, cyano, Q-6 alkyl, Q-6 haloalkyl, Q-6 alkoxy or Q-6 haloalkoxy), Q-6 alkoxycarbonyl(Q-6)alkyl, Q-6 alkenyl, Q-e alkynyl or N=C(CH3)2; R19 is phenyl (optionally substituted by halo, nitro, cyano, Ci-6 alkyl, Q-6 haloalkyl, Q-6 alkoxy or Q-6 haloalkoxy), Q-6 alkyl or Ci-6 haloalkyl; R16 and R17 are, independently, hydrogen, Q-8 alkyl, Q-7cycloalkyl(Q-4)alkyl, Q-6 haloalkyl, Ci-6 alkoxy(Q-6)alkyl, C3- cycloalkyl, Q-6 alkenyl, -6 alkynyl or Q-6 alkoxycarbonyl; and R18 is phenyl(Q-2)alkyl (wherein the phenyl group is optionally substituted by halo, nitro, cyano, Ci-6 alkyl, Ci-6 haloalkyl, Q-6 alkoxy or Q-6 haloalkoxy) or Q-6 alkyl.
R7 is more preferably Q-8 alkyl, Q-8 haloalkyl, Q-8 cyanoalkyl, Q-6 alkenyl, Q-6 alkynyl, Q- cycloalkyl, Q_7 halocycloalkyl, Q-7 cyanocycloalkyl, Q-3 alkyl(Q. )cycloalkyl, Q-3 alkyl(C3-7)halocycloalkyl, C5-6 cycloalkenyl, C3-7 cyclθ-dkyl(Q-6)alkyl, C5-6 cycloalkenyl(Q-6)alkyl, C2-6 haloalkenyl, Ci-6 cyanoalkenyl, Ci-6 alkoxy(Q-6)alkyl, -6 alkenyloxy(Q-6)alkyl, C3-6 alkynyloxy(Ci-6)alkyl, aryloxy(Ci-6)alkyl, Q-β carboxyalkyl, Q-6 alkylcarbonyl(Ci-6)alkyl, C2-6 alkenylcarbonyl(Q-6)alkyl, C2-6 alkynylcarbonyl(Q-6)alkyl, Ci-6 alkoxycarbonyl(Ci-6)alkyl, Q-e alkenyloxycarbonyl(Q-6)alkyl, C3-6 alkynyloxycarbonyl(Ci.6)alkyl, aryloxycarbonyl(Cι-6)alkyl, Q-6 alkylthio(Q-6)alkyl, Ci-e alkylsulfinyl(Q-6)alkyl, Ci-6 alkylsulfonyl(Q-6)alkyl, aminocarbonyl(Cι-6)alkyl, aminocarbonyl(C2-6)alkenyl, aminocarbonyl(C2-6)alkynyl, Q-6 alkylaminocarbonyl(Q- e)alkyl, di(Ci-6)alkylaminocarbonyl(Ci-6)alkyl, Q-6 alkylaminocarbonyl(Q-6)alkenyl, di(Cι-6)alkylarninocarbonyl(Ci-6)alkenyl, alkylaminocarbonyl(Ci-6)alkynyl, di(Ci-6)alkylaminocarbonyl(Ci-6)alkynyl, phenyl (optionally substituted by halo, nitro, cyano, Q.6 alkyl, Q-6 haloalkyl, Ci-6 alkoxy or Q-e haloalkoxy), pheny^Q-^alkyl (wherein the phenyl group is optionally substituted by halo, nitro, cyano, Q-6 alkyl, Ci-6 haloalkyl, Q. 6 alkoxy or Q-6 haloalkoxy), phenyl(Q-4)alkenyl, (wherein the phenyl group is optionally substituted by halo, nitro, cyano, Q-e alkyl, Q-6 haloalkyl, Q-6 alkoxy or Q-6 haloalkoxy), heteroaryl (optionally substituted by halo, nitro, cyano, Q-6 alkyl, Q-6 haloalkyl, Q-6 alkoxy or Q-6 haloalkoxy), heterocyclyl (wherein the heterocyclyl group is optionally substituted by halo, nitro, cyano, Q-6 alkyl, Ci-6 haloalkyl, Ci-6 alkoxy or Q-6 haloalkoxy), heteroaryl (Q.- alkyl (wherein the heteroaryl group is optionally substituted by halo, nitro, cyano, Ci-6 alkyl, Q-6 haloalkyl, Q-6 alkoxy or Q-6 haloalkoxy), heterocyclyl(Cι-4)alkyl (wherein the heterocyclyl group is optionally substituted by halo, nitro, cyano, Ci-6 alkyl, Q. 6 haloalkyl, Q-6 alkoxy or Q-6 haloalkoxy), R15O, Q-8 alkylthio, R16R17N or R18ON=C(R19); where R15 is Q_8 alkyl, Ci-6 haloalkyl; R19 is Q-6 alkyl, Ci-6 haloalkyl or phenyl (optionally substituted by halo, nitro, cyano, Q-6 alkyl, Q-6 haloalkyl, Q-6 alkoxy or Q-6 haloalkoxy); R16 and R17 are, independently, hydrogen, Q-8 alkyl, Q-7 cycloalkyl, Q-6 alkenyl, Q-6 alkynyl, C3.7 cycloalkyl(Cι-4)alkyl, C2-6 haloalkyl, Q-6 alkoxy(Q-6)alkyl, Q-6 alkoxycarbonyl, or R16 and R17 together with the N atom to which they are attached form a five, six or seven-membered heterocyclic ring which may contain one or two further heteroatoms selected from O, N or S and which may be optionally substituted by one or two Q-6 alkyl groups; and R18 is Ci-6 alkyl or phenyl(Q-2)alkyl (wherein the phenyl group is optionally substituted by halo, nitro, cyano, Ci-6 alkyl, Q-6 haloalkyl, Ci-6 alkoxy or Q-6 haloalkoxy); and R7 is more preferably Q-8 alkyl, Q-8 haloalkyl, Q-8 cyanoalkyl, Q-7 cycloalkyl, Q.3 alkyl(C3_7)cycloalkyl, Q-6 alkoxy(Q-6)alkyl, heterocyclyl (wherein the heterocyclyl group is optionally substituted by halo, nitro, cyano, Q-6 alkyl, Ci-6 haloalkyl, Q-6 alkoxy or Ci-6 haloalkoxy) or R16R17N; where R16 and R17 are, independently, Q-8 alkyl or together with the N atom to which they are attached form a five, six or seven-membered heterocyclic ring which may contain one or two further heteroatoms selected from O, N or S and which may be optionally substituted by one or two Q-6 alkyl groups.
It is further preferred that R7 is Q-8 alkyl, Q-8 haloalkyl, Q-8 cyanoalkyl, Q-7 cycloalkyl(Q-6)alkyl, -6 cycloalkenyl(Q-6)alkyl, Ci-6 alkoxy(Q-6)alkyl, Q-e alkenyloxy(Q-6)alkyl, -6 alkynyloxy(Q-6)alkyl, _tryloxy(Q-6)alkyl, Q-6 carboxyalkyl, Q-6 alkylcarbonyl(Q-6)alkyl, Q-β alkenylcarbonyl(Q-6)alkyl, Q-6 alkynylcarbonyl(Q-6)alkyl, Q-6 alkoxycarbonyl(Q-6)alkyl, -6 alkenyloxycarbonyl(Q_6)alkyl, Q-6 alkynyloxycarbonyl- (Q-6)alkyl, aryloxycarbonyl(Ci-6)alkyl, Q-6 alkylthio(Cι-6)alkyl, Q-6 a]kylsulfinyl(Q-6) alkyl, Q-6 alkylsulfonyl(Q-6)alkyl, arninocarbonyl(Q-6)alkyl, Ci-6 alkylarninocarbonyl(Q-6) alkyl, di(Q-6)alkylaminocarbonyl(Q-6)alkyl, phenyl(Q-4)alkyl (wherein the phenyl group is optionally substituted by halo, nitro, cyano, Ci-6 alkyl, Q-6 haloalkyl, Ci-6 alkoxy or Q-6 haloalkoxy), heteroaryl(Q-4)alkyl (wherein the heteroaryl group is optionally substituted by halo, nitro, cyano, Q_6 alkyl, Ci-6 haloalkyl, Q.6 alkoxy or Q-6 haloalkoxy), heterocyclyl- (CM) alkyl (wherein the heterocyclyl group is optionally substituted by halo, nitro, cyano, Q-6 alkyl, Q-6 haloalkyl, Ci-6 alkoxy or Q_6 haloalkoxy), Q-6 alkenyl, Q-6 haloalkenyl, Ci-6 cyanoalkenyl, -6 cycloalkenyl, aminocarbonyl(Q-6)alkenyl, Q-6 alkylaminocarbonyl(Q-6) alkenyl, di(Q6)alkylarmnocarbonyl(Q-6)alkenyl, phenyl(Q-4)alkenyl (wherein the phenyl group is optionally substituted by halo, nitro, cyano, Ci-6 alkyl, Ci-e haloalkyl, Q-6 alkoxy or Ci-6 haloalkoxy), Q-6 alkynyl, aminocarbonyl(Q-6)alkynyl, alkylaminocarbonyl(Q-6) alkynyl, di(Q-6)alkylan nocarbonyl(Q-6)alkynyl, Q-7 cycloalkyl, Q-7 halocycloalkyl, Q-7 cyanocycloalkyl, Q-3 alkyl(C3- )cycloalkyl, Q-3 alkyl(C3-7)halocycloalkyl, phenyl (optionally substituted by halo, nitro, cyano, Q-6 alkyl, Q-6 haloalkyl, Q-6 alkoxy or Ci-6 haloalkoxy), heteroaryl (optionally substituted by halo, nitro, cyano, Ci-6 alkyl, Q-6 haloalkyl, Q-6 alkoxy or Q-6 haloalkoxy), heterocyclyl (optionally substituted by halo, nitro, cyano, Ci-6 alkyl, Q-6 haloalkyl, Q-6 alkoxy or Q-6 haloalkoxy), Q-8 alkylthio, R15O, R16R17N or R18ON=C(R19); where R15 is Q-8 alkyl or Ci-6 haloalkyl; R19 is phenyl (optionally substituted by halo, nitro, cyano, Q.6 alkyl, Q-6 haloalkyl, Q-6 alkoxy or Q-6 haloalkoxy), Q_6 alkyl or Ci-6 haloalkyl; R16 and R17 are, independently, hydrogen, Q-8 alkyl, -7 cycloalkyl(Q-4)alkyl, Q-6 haloalkyl, Q.6 alkoxy(Q-6)alkyl, Q.7 cycloalkyl, Q-6 alkenyl, -6 alkynyl or Q-e alkoxycarbonyl; and R18 is phenyl(Q_2)alkyl (wherein the phenyl group is optionally substituted by halo, nitro, cyano, Q-6 alkyl, Q.6 haloalkyl, Ci-6 alkoxy or Ci-e haloalkoxy) or Q-e alkyl.
It is even more preferred that R7 is Q-8 alkyl, Q-8 haloalkyl, Q_8 cyanoalkyl, Q-6 alkoxy (Q-6) alkyl, Q-7 cycloalkyl, Q-3 alkyl (Q.7) cycloalkyl, heterocyclyl (optionally substituted by halo, nitro, cyano, Q_6 alkyl, Ci-6 haloalkyl, Q.6 alkoxy or Q-6 haloalkoxy) or di(Q.8)alkylamino. It is yet more preferred that R7 is Q-8 alkyl, Q-8 haloalkyl, Q.8 cyanoalkyl, Q.6 alkoxy (Q-6) alkyl, Q.7 cycloalkyl, Q.3 alkyl (Q-7) cycloalkyl, heterocyclyl (optionally substituted by Ci-6 alkyl) or di(Q-8)alkylamino.
R7 is most preferably Q-8 alkyl, Q-8 haloalkyl, Q-8 cyanoalkyl, Q-7 cycloalkyl, Q-3 alkyl(C3-7)cycloalkyl, Q-6 alkoxy(Q-6)alkyl or R16R17N; where R16 andR17 are, independently, Cι_8 alkyl or together with the N atom to which they are attached form a five, six or seven-membered heterocyclic ring which may contain one further heteroatom selected from O, N or S and which may be optionally substituted by one or two Ci-6 alkyl groups. It is preferred that R is hydrogen, halogen, nitro, cyano, Q-8 alkyl, -6 haloalkyl, Ci-6 cyanoalkyl, Q-7 cycloalkyl(Q-6)alkyl, Q-6 alkoxy(Q-6)alkyl, Q-6 alkoxycarbonyl(Q.6)alkyl, Q-6 aιkyιcarbonyl(Q.6)alkyl, Q-6 alkylaminocarbonyl(Q-6)alkyl, di(Q-6)alkylamino-carbonyl(Ci-6)alkyl, phenyl(Q-6)alkyl (wherein the phenyl group is optionally substituted by halo, nitro, cyano, Q-6 alkyl, Ci-6 haloalkyl, Q-e alkoxy or Q.6 haloalkoxy), heteroaryl(Q-6)alkyl (wherein the heteroaryl group is optionally substituted by halo, nitro, cyano, Q-6 alkyl, Ci-6 haloalkyl, Ci-6 alkoxy or Q-6 haloalkoxy), Q-6 alkenyl, Q-6 haloalkenyl, -6 alkynyl, C3-7 cycloalkyl, Q.6 alkoxycarbonyl, Q-6 alkylcarbonyl, Ci-e alkylaminocarbonyl, di(Ci-6)alkylaminocarbonyl, phenyl (optionally substituted by halo, nitro, cyano, Q-6 alkyl, Q-6 haloalkyl, Q_6 alkoxy or Ci-6 haloalkoxy) or heteroaryl (optionally substituted by halo, nitro, cyano, Q-6 alkyl, Q-β haloalkyl, Ci-6 alkoxy or Q-6 haloalkoxy).
It is more preferred that R8 is hydrogen, halogen, Q-8 alkyl or Ci-6 haloalkyl.
It is preferred that R9 is cyano, nitro, Ci-6 alkyl, Q.6 haloalkyl, Q-7 cycloalkyl(Q-6)alkyl, Q-7 cycloalkyl, CH2(Q-6)alkenyl, CH2(Q-6)alkynyl, phenyl
(optionally substituted by halo, nitro, cyano, Q-6 alkyl, Q-6 haloalkyl, Ci-6 alkoxy or Q-6 haloalkoxy), heteroaryl (optionally substituted by halo, nitro, cyano, Q_6 alkyl, Ci-6 haloalkyl, Q.6 alkoxy or Q-6 haloalkoxy), Q-6 alkylcarbonyl, Q.6 alkoxycarbonyl, Q.6 alkylamino, ck(Q-6)alkylanτino, Ci-6 alkylcarbonylamino, Q.6 alkoxycarbonylamino, Q-6 alkoxy, Q-6 alkylthio, Ci-6 haloalkylthio, Ci-6 alkylsulfinyl, Ci-6 haloalkylsulfinyl, Ci-e alkylsulfonyl, Q-6 haloalkylsulfonyl, arylthio, arylsulfinyl, arylsulfonyl or (Q. 6)alkylcarbonyloxy.
It is preferred that R10 is hydrogen, Q-8 alkyl, Q-6 haloalkyl, Q-6 cyanoalkyl, Q-6 alkenyl, Q-6 haloalkenyl, Q-β alkynyl, Q-7 cycloalkyl, Q-7 cycloalkyl(Q-6)alkyl, Ci-6 alkoxy(Q-6)alkyl, Q.6 alkoxycarbonyl, Ci-6 alkylcarbonyl, Ci-6 alkylaminocarbonyl, di(Q-6)alkylaminocarbonyl, phenyl (optionally substituted by halo, nitro, cyano, Ci-6 alkyl, Ci-e haloalkyl, Q-6 alkoxy or Ci-e haloalkoxy) or heteroaryl (optionally substituted by halo, nitro, cyano, Q-6 alkyl, Q-6 haloalkyl, Ci-6 alkoxy or Q-6 haloalkoxy).
It is more preferred that R10 is hydrogen, Q-8 alkyl or Q-6 haloalkyl. Certain compounds of formula (IA) are described in WO 00/06566, and recited in
Tables A1-A70, B1-B70, C1-C70, D1-D70, E1-E70, F1-F70, G1-G70, H1-H70, 11-170, J1-J70, K1-K70, L1-L70, M1-M70, N1-N70, O1-O70, P1-P70, Q1-Q70, R1-R70, S1-S70, T1-T70, U1-U70 and V1-V20 of that document.
The natures of B, Z and R4 - R7 are typically such that the right hand bicyclic ring system is vulnerable to nucleophilic attack and/or ring opening, particularly in the presence of a strong base. Thus, R7 may be an electron-withdrawing group, such as haloalkyl (in particular a poly-rhalogenated group such as QF7).
Compounds of formula (II) are either known compounds or may be prepared from commercially available starting materials by methods described in the literature (see, for example, C. Oliver Kappe, Robert Flammang, and Curt Wentrup, Heterocycles, Vol. 37, No. 3, 1615, (1994); A. Adams and R. Slack, J. Chem. Soc, 3061, (1959); and Ronald E Hackler, Kenneth W. Burow, Jr., Sylvester V. Kaster and David I. Wickiser, J. Heterocyclic Chem, 26, 1575, (1989)). A compound of formula (HI) in which L is OH (Ilia) may be prepared by hydrolysis of the corresponding compound (lTlb) in which L is Ci-6 alkyl, by a method known in the art. The hydrolysis may be carried out under neutral, basic or acidic conditions; the conditions should be chosen such that substituent R7 is unchanged during the hydrolysis reaction. Compounds of formula (nib) are capable of ready hydrolysis under different conditions, as known in the literature. Suitable compounds of formula (IDb) may be selected, for example, by reference to Theodora W. Greene, Protective Groups in Organic Synthesis, Chapter 5, John Wiley and Sons, New York, 1981.
A compound of formula (Hla) may be converted to for instance an acid chloride, anhydride or chloroformate suitable for use in the method of the present invention; such procedures are well known and are described, for example, in J. March, Advanced Organic Chemistry, Third Edition, John Wiley and Sons, New York, 1985, pages 370-376 and references therein.
Alternatively, compounds of formula (πi)/(ffla)/(IιTb) may be prepared by cyclisation of a compound of formula (V):
Figure imgf000025_0001
(N) where A, L and R4-R6 are as defined above in relation to formula (DI) and R70 and R71 are cyclisable groups, such as in formula (Na):
Figure imgf000025_0002
(Na)
(see, for example, David W. Dunwell, Delme Evans, Terence A. Hicks, J. Med. Chem.,
1975, Vol. 18, No. 1, 53; Abdou O. Abdelhamid, Cyril Parkanyi, S.M. Khaledur Rashid and
Winston D. Lloyd, J. Heterocyclic Chem., 25, 403, (1988); Teruyuki Kondo, Sungbong Yang, Keun-Tae Huh, Masanobu Kobayashi, Shinju Kotachi and Yoshihisa Watanabe,
Chemistry Letters, 1275-1278, 1991; Dale L. Boger, J. Org. Chem., 43, No 11, 2296, 1978 ). The substituent R7 may be an atom or group which itself may be converted into other functional groups; procedures are known in the literature for such transformations involving benzoxazoles and benzothiazoles (for example, Lazer, Edward S., Adams, Julian; Miao, Clara K.; Farina, Peter, Eur. Pat. Appl. EP0535521). Alternatively R may contain atoms or groups which may be replaced by other moieties under known conditions.
A compound of formula (N) may be prepared by reduction of a compound of formula (NI):
Figure imgf000026_0001
(NI) where A, Z, L and R4 - R6 are as defined above in connection with formula (HI), and such procedures are known in the art (see, for example, J. March, Advanced Organic Chemistry, Third Edition, John Wiley and Sons, New York, 1985, and references therein).
A compound of formula (VI), wherein Z is oxygen, may be prepared by the nitration of a compound of formula (NH):
Figure imgf000026_0002
(VΓJ) under known conditions. A compound of formula (NI) in which Z is sulfur may be prepared from a compound of formula (NI) in which Z is oxygen, using conditions similar to those described by J. Scheigetz, R. Zamboni and B. Roy, Synth. Commun., 25 (1995) (18), pages 2791-2806. A compound of formula (NI) in which Z is nitrogen may be prepared from a compound of formula (NH) by a sequence of acylation, nitration and deacylation, using conditions known in the art.
In the trialkyl-aluminium agent, R , R and R are each independently selected from alkyl groups, preferably Q-Q alkyl groups, more preferably either methyl or ethyl, most preferably methyl such as in the preferred reagent Me3 Al. Suitable solvents for the reaction include toluene, benzene, hexane and other inert hydrocarbons. Selection of an appropriate solvent for given reactants (H) and (HI) is well within the capabilities of the average person skilled in the art.
The method of the invention is suitably effected at a fairly high temperature, for instance between about 40°C and 120°C, more preferably between about 50°C and 100°Q most preferably between about 70°C and 100°C. Reaction times may vary, but in general the reaction will be completed in between 2 and 8 hours, more typically between 2 and 4 hours. After the reaction, the reaction mixture may suitably be left to stand at room temperature for between 12 and 48 hours, then worked up prior to product isolation. Suitably, between 1 and 1.2 molar equivalents of the trialkyl-aluminium agent may be used for between 1 and 1.2 molar equivalents of the amine reactant (H).
Suitable reaction conditions may in particular be derived from the published literature on the Weinreb reaction (supra).
The reactant (HI) is preferably added to a pre-prepared mixture of the amine isothiazole (JJ) and the trialkyl-aluminium agent.
A second aspect of the present invention provides a dialkylaluminium intermediate compound (X):
Figure imgf000027_0001
(X) formed during the method of the first aspect. This intermediate has the general formula (H) but with the group A1-R50R51 attached to the amine nitrogen. R50 and R51 are as defined above in connection with the trialkyl-aluminium agent.
A third aspect of the present invention provides a method for the preparation of a compound of formula (I) as defined above, which method involves reacting a compound of formula (HI) (also as defined above) with the intermediate compound (X) of the second aspect of the invention.
Certain compounds of formula I, NIH and IX are novel and as such form a further aspect of the invention.
The following examples demonstrate the preparation of two pesticidally active benzoxazoles (VIH) and (IX), using Weinreb chemistry to react together an amino-isothiazole of the formula (H) and a benzoxazole ester of the formula (HI), in the presence of a trialkyl-aluminium catalyst.
EXAMPLE 1
Figure imgf000028_0001
Toluene, hexane
CI4H10F7NO3 C18H13CIF7N3θ2S MW 373 MW 503.5 Compound (VDIa) Compound (Vm)
Materials
Figure imgf000028_0002
Method The amino-isothiazole (4.77 g) was dissolved in toluene (30 ml) and washed in with further toluene (10 ml) and the mixture stirred at room temperature under nitrogen. Trimethylaluminium (2M, 15.06 ml) was charged to a pressure equalising dropping funnel via a cannula and added dropwise over 20 mms maintaining the reaction temperature between 20 and 25°C (water bath cooling). During this addition evolution of methane was observed and around three quarters of the way through the addition a solid began to fall out of solution resulting in a thin easily stirred orange slurry. The slurry was stirred at room temperature for 30 mins and then a solution of the benzoxazole ester (NJHa) (9.854 g) in toluene (25 ml) was added dropwise over 20 mins (little exotherm). The resultant orange suspension was heated at reflux (reflux temp ~ 96°C) under nitrogen, resulting in the suspension dissolving to afford a dark red solution. The progress of the reaction was followed by HPLC (HP1100, KROMASIL KR100-3.5C18-35AS, 35 x 3.2 mm column, water/acetonitrile 98:2 to 10:90 gradient, 1.5 ml/min, UN 254 nm) of samples (10% v/v H2SO-t/EtOAc). After 70 mins - HPLC retention time (rt) 3.39 (2.8%) - amine isothiazole; 4.84 (20.8%) - toluene; 6.18 (6.3%) - ester (VHIa); 6.34 (4.3%) - bώ-alkylated benzoxazole ester (impurity in starting material); 6.68 (61.2%) - Compound (NHI). After 3 hours - HPCL rt 3.39 (1.0%); 4.85 (20.7%) - toluene; 6.18 (0.6%); 6.35 (4.3%); 6.68 (69.1%) - Compound (NHI). Note - it appears that the bw-alkylated ester present in the starting material does not react in the Weinreb reaction. The mixture was left undisturbed at room temperature for 40 hours. The reaction mixture was then worked up by diluting with EtOAc (70 ml) with stirring and cooling the resultant brown solution in an ice bath while aqueous 10% v/v sulphuric acid (16 ml) was added dropwise over 20 mins. During this addition the temperature of the mixture was maintained at <10°C (exothermic). Thereafter the mixture was allowed to warm to room temperature as effervescing subsided. It was stirred at room temperature for 30 mins and the layers then separated (some solid at the interface). The aqueous layer was re-extracted with further EtOAc (2 x 30 ml) and the combined extracts were washed with brine (100 ml), dried over magnesium sulphate, filtered and concentrated under reduced pressure to give an orange solid, yield 13.30 g. Gas chromatography results (CPSIL 5CB, 100- 270°C, 16°C/min) rt 10.62 (0.9%); 10.79 (93.7%) - Compound (NHI); 11.15 (5.4%).
ΝMR in CDC13 -consistent with crude product. HPLC rt 3.40 (2.2%) - amino isothiazole; 6.19 (2.1%) - ester (VHIa); 6.35 (6.5%) - impurity in starting material; 6.69 (82.5%) - Compound (NHI). The product (Compound (NIH)) was purified by recrystallisation from 1,2-dichloroethane (20 ml)/hexane (50 ml) to give a cream solid. Results
Yield: 9.80g (74%) HPLC: UN detection (254 nm): rt 6.35 (6.2%); 6.68 (92.1%) evaporative light-scattering detection: rt 6.36 (1.3%); 6.77 (91.6%) ΝMR in CDC13: consistent with pure product.
GC (CPSIL 5CB, 100-270°C, 16°C/min): rt 10.79 (100%) Mpt: 149.6 - 150.8°C (corrected). EXAMPLE 2 This experiment attempted a reaction between the benzoxazole ester (TXa) and the amino-aluminium species generated from trimethyl-aluminium and the aminoisothiazole (IXb), to form Compound (IX):
Compound (IXb) / Me3Al toluene/hexane
Figure imgf000030_0002
Compound (IXa) Compound (TX) [489.5]
Materials
Figure imgf000030_0003
Method
A 3-necked round bottomed flask was pre-purged with nitrogen for 15 minutes and the nitrogen purging was continued during the subsequent reaction.
Compound (JXb) (5-amino-4-chloro-3-ethylisothiazole) was dissolved in toluene (200 ml) (slightly endothermic), charged to the flask and the residuals washed in with more solvent (25 ml). The mixture was stirred for 15 min, under nitrogen purging, at room temperature. The trimethylaluminium solution was added, via a pressure-equalising addition funnel, slowly over 30 mins. The exotherm was easily controlled (by water bath), holding the temperature in the range 21° to 25°C; there was continuous evolution of methane throughout and for about 10 mins after. After addition of about half of the trimethylaluminium solution, solid had begun to precipitate, finally forming a thin, easily stirred slurry. This slurry was stirred at room temperature for 30 mins, then the ester (IXa) (in dry toluene, 125 ml) was added dropwise over 30 mins (negligible exotherm). The resulting thin slurry was heated to reflux, under nitrogen (by about 80°C a solution had apparently reformed).
The mixture was refluxed for 2 hours at 94°C to 96°C (pressure of hexanes in solvent mixture). It was then cooled slightly and a sample taken for monitoring the reaction.
Results & subsequent analysis The reaction mixture was sampled for HPLC thus: the sample was removed, diluted approximately 1:1 with ethyl acetate and carefully shaken with aqueous 10% v/v sulphuric acid. The organic phase was dried over magnesium sulphate, then vacuum evaporated. The residue was dissolved in acetonitrile for injection into the column.
The progress of the reaction was followed by HPLC (HPl 100, KROMASIL KR100-3.5C18- 35AS, 35 x 3.2 mm column, water/acetonitrile 98:2 to 10:90 gradient, 1.5 ml/min, UN 254 nm). The results were: rt = 3.384 [2.6%] (isothiazole (IXb)); rt = 6.335 [84.3%] (the product Compound (TX)); no ester (IXa) (rt = 5.830) observed.
Thus heating was stopped and the mixture allowed to cool to room temperature and left to stand overnight. The following day, the reaction mixture was diluted with ethyl acetate (350 ml), stirred and the resulting solution cooled in an ice bath. The cooled solution was treated with ~ 10% v/v aqueous sulphuric acid (90 ml), dropwise, over 45 mins (the initial addition gave a rapid exothermic reaction and the temperature rose to ~20°C, but it subsequently became possible to keep the temperature <10°C, allowing for a controlled effervescent hydrolysis, the exotherm being controlled by the ice bath). The mixture was then allowed to warm to room temperature over 30 mins, as effervescence subsided.
The phases were then separated - a little white solid present in the (lower) aqueous phase caused slight interference with separation. The aqueous phase was re-extracted with more ethyl acetate (2 x 250 ml). The combined organic phase (containing some of the white solid) was washed with saturated aqueous ammonium chloride (500 ml) - this possibly removed some of the solid into solution, but was still a slow separation - then brine (1 x 500 ml).
Finally the deep red organic phase was dried over magnesium sulphate.
The dried solution was filtered and concentrated to give an orange-yellow solid.
Yield of crude product = 68.6 g [>100%; contains solvent] The crude reaction product was analysed by HPLC (HPl 100, KROMASIL KR100-3.5C18-
35AS, 35 x 3.2 mm column, water/acetonitrile 98:2 to 10:90 gradient, 1.5 ml/min, UN 254 nm). The results were: rt = 6.332 (compound (TX) = 89.76% pure) with -1.62% amino-isothiazole (IXb) + other impurities. Following recrystallization from 1,2 dichloroethane (100 ml) and hexane (200 ml) [a fine pale yellow solid was filtered off and dried]:
Yield: 50 g (73.14% yield)
NMR: consistent with required product.
HPLC (HPl 100, KROMASIL KR100-3.5C18-35AS, 35 x 3.2 mm column, water/acetonitrile 98:2 to 10:90 gradient, 1.5 ml/min, UN 254 nm): rt = 6.345 (compound
(IX) = 99.0% pure).
Melting point: 128 - 129°C
(The recrystallization filtrate liquors were concentrated to give an orange thick oily gum.)

Claims

1. A method for the preparation of a compound of formula (I):
Figure imgf000033_0001
wherein A is optionally substituted Q-6 alkylene, optionally substituted Q-6 alkenylene, optionally substituted Q-6 alkynylene, optionally substituted cycloalkylene, optionally substituted Q-6 alkylenoxy, optionally substituted oxy(Q-6)alkylene, optionally substituted Q_6 alkylenethio, optionally substituted thio(Q-6)alkylene, optionally substituted Q.6 alkylenamino, optionally substituted amino(Q-6)alkylene, optionally substituted [Ci-e alkyleneoxy(Q-6)-ilkylene], optionally substituted [Ci-6 alkylenethio(Cι-6)alkylene], optionally substituted [Ci-e alkylenesulfinyl(Cι.6)alkylene], optionally substituted [Ci-6 alkylenesulfonyl(Q-6)alkylene] or optionally substituted [Q-6 alkyleneamino(Q-6)alkylene] ; B is N, N-oxide or CR8; Z is O, S or NR10;
R1 is hydrogen, halogen, optionally substituted Q-6 alkyl, optionally substituted Q-β alkenyl, optionally substituted Q-6 alkynyl, optionally substituted Q.6 alkoxy, optionally substituted Q-6 alkylthio, optionally substituted C3-7 cycloalkyl, cyano, nitro or SF5; R2 is hydrogen, halogen, optionally substituted Q-6 alkyl, optionally substituted Q-6 alkenyl, optionally substituted Q-6 alkynyl, optionally substituted Ci-6 alkoxy, optionally substituted Q-6 alkylthio, optionally substituted Ci-6 alkylsulfinyl, optionally substituted Ci-6 alkylsulfonyl, cyano, nitro, formyl, optionally substituted Q_6 alkylcarbonyl, optionally substituted Ci-6 alkoxycarbonyl, SF5 or RnON=C(R12); or R and R together with the atoms to which they are attached may be joined to form a five, six or seven-membered saturated or unsaturated, carbocylic or heterocyclic ring which may contain one or two heteroatoms selected from O, N or S and which is optionally substituted by Ci-6 alkyl, Q-6 haloalkyl or halogen; R3 is hydrogen, optionally substituted Q-10 alkyl, optionally substituted [Q-6 alkenyl(Q-6)alkyl], optionally substituted [Q-6 alkynyl(Q-6)alkyl], optionally substituted Q-7 cycloalkyl, optionally substituted Q-10 alkylcarbonyl, optionally substituted CMO alkoxycarbonyl, formyl, optionally substituted Q.io alkylaminocarbonyl, optionally substituted di(Q-ιo)alkylaminocarbonyl, optionally substituted phenoxycarbonyl, optionally substituted Ci-e alkylthio, optionally substituted Ci-6 alkylsulfinyl, optionally substituted Ci-6 alkylsulfonyl, optionally substituted Q-6 arylthio, optionally substituted Ci-6 arylsulfinyl, optionally substituted Q-6 arylsulfonyl or R13R14NS(O)p; p is 0, 1 or 2;
R4, R5 and R6 are, independently, hydrogen, halogen, optionally substituted Ci-6 alkyl, optionally substituted Q-6 alkoxy, optionally substituted Q-6 alkylthio, optionally substituted Q-e alkylsulfinyl, optionally substituted Q-e alkylsulfonyl, cyano, nitro, optionally substituted Q-6 alkylcarbonyl, optionally substituted Ci-6 alkoxycarbonyl or SF5;
R7 is hydrogen, halogen, cyano, optionally substituted Ci.20 alkyl, optionally substituted Q-20 alkenyl, optionally substituted Q-20 alkynyl, optionally substituted Q-7 cycloalkyl, optionally substituted .6 cycloalkenyl, formyl, optionally substituted Q-20 alkoxycarbonyl, optionally substituted Q-20 alkylcarbonyl, aminocarbonyl, optionally substituted Q-2o alkylaminocarbonyl, optionally substituted di(Ci-2o)alkylaminocarbonyl, optionally substituted aryloxycarbonyl, optionally substituted arylcarbonyl, optionally substituted arylaminocarbonyl, optionally substituted N-(Q-6)alkyl-N-arylarninocarbonyl, optionally substituted diarylaminocarbonyl, optionally substituted heteroaryloxycarbonyl, optionally substituted heteroarylcarbonyl, optionally substituted heteroarylaminocarbonyl, optionally substituted N-(Q-6)alkyl-N-heteroarylaminocarbonyl, optionally substituted diheteroarylaminocarbonyl, optionally substituted phenyl, optionally substituted heteroaryl, optionally substituted heterocyclyl, SH, optionally substituted Q.2o alkylthio, optionally substituted Q_2o alkylsulfinyl, optionally substituted Q.2o alkylsulfonyl, optionally substituted arylthio, optionally substituted arylsulfinyl, optionally substituted arylsulfonyl, R15O, R16R17N or R18ON=C(R19); R is hydrogen, halogen, nitro, cyano, optionally substituted Q-8 alkyl, optionally substituted -6 alkenyl, optionally substituted C2-6 alkynyl, optionally substituted C3-7 cycloalkyl, optionally substituted Ci-6 alkoxycarbonyl, optionally substituted Q-6 alkylcarbonyl, optionally substituted Ci-6 alkylaminocarbonyl, optionally substituted di(Ci-6)alkylaminocarbonyl, optionally substituted phenyl or optionally substituted heteroaryl; R9 is hydrogen, cyano, nitro, optionally substituted Q-6 alkyl, optionally substituted
Q-7 cycloalkyl, optionally substituted (Q-6)alkenyl(Q_6)alkyl, optionally substituted (Q-6)alkynyl(Q-6)alkyl, optionally substituted phenyl, optionally substituted heteroaryl, optionally substituted Ci-6 alkylcarbonyl, optionally substituted Ci-6 alkoxycarbonyl, optionally substituted Q-6 alkylamino, optionally substituted di(Cι-6)alkylamino, optionally substituted Ci-6 alkylcarbonylamino, optionally substituted Ci-6 alkoxycarbonylamino, optionally substituted Q-6 alkoxy, optionally substituted Q-6 alkylthio, optionally substituted Q-6 alkylsulfinyl, optionally substituted Q-e alkylsulfonyl, optionally substituted arylthio, optionally substituted arylsulfinyl, optionally substituted arylsulfonyl or Ci-6 alkylcarbonyloxy; R10 is hydrogen, cyano, optionally substituted Q.8 alkyl, optionally substituted [Q.6 alkenyl(Q.6)alkyl], optionally substituted [ -6 alkynyl(Q-6)alkyl], optionally substituted C3.7 cycloalkyl, optionally substituted [Q.7 cycloalkyl(Q-6)alkyl], Q-6 alkoxy(Q.6)alkyl, optionally substituted Q-e alkoxycarbonyl, optionally substituted Q-6 alkylcarbonyl, optionally substituted Q-6 alkylaminocarbonyl, optionally substituted di(Q-6)alkylarr-inocarbonyl, optionally substituted phenyl, optionally substituted heteroaryl, optionally substituted alkylsulfonyl or optionally substituted arylsulfonyl;
R and R are, independently, hydrogen, optionally substituted phenyl (Q-2)alkyl or optionally substituted Q-20 alkyl; R12 and R19 are, independently, hydrogen, optionally substituted phenyl or optionally substituted Q-6 alkyl;
R13 and R14 are, independently, optionally substituted Q-6 alkyl; or R13 and R14 together with the N atom to which they are attached form a five, six or seven-membered heterocyclic ring which may contain one or two further heteroatoms selected from O, N and S and which is optionally substituted by one or two independently selected Q-6 alkyl groups;
R15 is hydrogen, optionally substituted Q-2o alkyl, optionally substituted [Q-20 alkenyl(Q-6)alkyl], optionally substituted [Q-20 aIkynyl(Q-6) alkyl], optionally substituted -7 cycloalkyl, optionally substituted aryl, optionally substituted heteroaryl, optionally substituted heterocyclyl, (Q-6)alkylCH=N, optionally substituted arylCH=N, optionally substituted [aryl(Q-6)alkyl]CH=N, optionally substituted heteroarylCH=N, optionally substituted [heterocyclyl(Q-6)alkyl]CH=N, optionally substituted arylC(CH3)=N, optionally substituted heteroarylC(CH3)=N or optionally substituted di(Ci-6)alkylC=N; and
R16 and R17 are, independently, hydrogen, optionally substituted Q-20 alkyl, optionally substituted Q.7 cycloalkyl, optionally substituted [Q-20 alkenyl(Q-6)alkyl], optionally substituted [Q-20 alkynyl(Q-6)alkyl], optionally substituted Ci.20 alkoxycarbonyl, optionally substituted phenoxycarbonyl, formyl, optionally substituted Q.20 alkylcarbonyl, optionally substituted Ci.20 alkylsulfonyl or optionally substituted phenylsulfonyl, the method involving reacting together a compound of the formula (H):
R2
Figure imgf000036_0001
(π) wherein R1, R2 and R3 are as defined above in relation to formula (I), and a compound of formula (HI):
Figure imgf000036_0002
(HI) in which A, B, Z and R4 - R7 are as defined above in relation to formula (I) and L is a leaving group, in the presence of a trialkyl-aluminium compound R50R51R52A1 where R50, R51 and R52 are each independently selected from Q-io alkyl.
2. A method according to claim 1, wherein in the compound (HI), L is halo or R30-O-, where R30 is hydrogen or a Q.6 alkyl group.
3. A method according to claim 2, wherein in the compound (HI), L is R30-O-.
4. A method according to any one of the preceding claims, wherein the compound (IH) is base- and/or nucleophile-sensitive.
5. A method according to any one of the preceding claims, wherein in the compound (HI), B is nitrogen and Z is oxygen.
6. A method according to any one of the preceding claims, wherein in the compound (IH), the substituent R7 is electron withdrawing.
7. A method according to claim 6, wherein R7 is a haloalkyl group.
8. A method according to claim 7, wherein R7 is QF7.
9. A method according to any one of the preceding claims, wherein in the ttrriiaallkkyyll--aalluummiinniiuumm aaggeenntt,, AA11RR5500RR51R52, R50, R51 and R52 are each independently selected from Q-Q alkyl groups.
10. A method according to claim 9, wherein R50, R51 and R52 are each independently selected from either methyl or ethyl.
11. A method according to claim 10, wherein the trialkyl-aluminium agent is Me3Al.
12. A method according to any one of the preceding claims, wherein the compound (HI) is added to a pre-prepared mixture of the compound (H) and the trialkyl-aluminium agent.
13. A method according to any one of the preceding claims, wherein the compound (I) produced by the method is a compound of formula (IA):
Figure imgf000037_0001
wherein A, B, Y, Z, R1, R2 , R3, R4, R5, R6 and R7 are as defined in the preceding claims.
14. A method for the preparation of a compound of formula (I) or (IA), as defined in claim 1 or claim 13, the method being substantially as herein described.
15. An intermediate compound of the formula (X):
Figure imgf000038_0001
(X) wherein R1, R2 , R3, R50 and R51 are as defined in any one of the preceding claims.
16. A method for the preparation of a compound of formula (I) as defined in claim 1, the method involving reacting a compound of formula (IH) (also as defined in claim 1) with an intermediate compound (X) according to claim 15.
PCT/GB2002/000331 2001-01-26 2002-01-25 Acylation of amino-isothiazoles using trialky-aluminium agents Ceased WO2002059119A1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB0102110.4 2001-01-26
GB0102110A GB0102110D0 (en) 2001-01-26 2001-01-26 Chemical process

Publications (1)

Publication Number Publication Date
WO2002059119A1 true WO2002059119A1 (en) 2002-08-01

Family

ID=9907610

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/GB2002/000331 Ceased WO2002059119A1 (en) 2001-01-26 2002-01-25 Acylation of amino-isothiazoles using trialky-aluminium agents

Country Status (2)

Country Link
GB (1) GB0102110D0 (en)
WO (1) WO2002059119A1 (en)

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2000006566A1 (en) * 1998-07-30 2000-02-10 Syngenta Limited Benzazoles: benzoxazole, benzthiazole and benzimidazole derivatives

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2000006566A1 (en) * 1998-07-30 2000-02-10 Syngenta Limited Benzazoles: benzoxazole, benzthiazole and benzimidazole derivatives

Non-Patent Citations (2)

* Cited by examiner, † Cited by third party
Title
BASHA A ET AL: "A mild, general method for conversion of esters to amides", TETRAHEDRON LETTERS, no. 48, November 1977 (1977-11-01), pages 4171 - 4173, XP002197154 *
BELL I M ET AL: "Efficient synthesis of 1-heterocyclic-3-aminopyrrolidinones", TETRAHEDRON LETTERS, vol. 41, no. 8, February 2000 (2000-02-01), pages 1141 - 1145, XP004188576 *

Also Published As

Publication number Publication date
GB0102110D0 (en) 2001-03-14

Similar Documents

Publication Publication Date Title
KR101961972B1 (en) Production method for 4,4-difluoro-3,4-dihydroisoquinoline derivative
EP3956318A1 (en) Process for the preparation of microbiocidal oxadiazole derivatives
CN108822053A (en) The method for being used to prepare substituted seromycin
JPH06135948A (en) Styrene derivative or its salt
KR20110106840A (en) Method for producing optically active carboxylic acid
JPH0656751A (en) Cyclopentane- and cyclopentene-beta-amino acids
KR20080012176A (en) Caspase Inhibitors Including Pyridazinone Structures
Collier et al. Hydroboration–Suzuki cross coupling of unsaturated amino acids; the synthesis of pyrimine derivatives
WO2002059119A1 (en) Acylation of amino-isothiazoles using trialky-aluminium agents
Li et al. An efficient enantioselective synthesis of florfenicol via a vanadium-catalyzed asymmetric epoxidation
Drummond et al. Asymmetric synthesis of allylic secondary alcohols: a new general approach for the preparation of α-amino acids
AU2007318401A1 (en) Caspase inhibitors based on pyridazinone scaffold
WO2014144500A2 (en) Methods of synthesizing a difluorolactam analog
TWI320305B (en) Fungicidal composition for controlling diseases of paddy rice
Ramachandran et al. Preparation of N-protected allylic amines and α-methylene-β-amino acids from vinylalumination/Baylis–Hillman products via tandem SN2′ substitution–Overman rearrangement
US6825353B2 (en) Process for producing quinolonecarboxylic acids and intermediates thereof
Colpaert et al. Asymmetric synthesis of new chiral N-sulfinyl 2, 2-disubstituted aziridines by Grignard additions across α-chloro N-sulfinyl ketimines
EP1928869B1 (en) Chemical process
SU610490A3 (en) Method of preparing oxazole derivatives
WO2000015625A2 (en) Methods of making dihydropyrone hiv protease inhibitors
Milcent et al. Trifluoromethyl nitrones: from fluoral to optically active hydroxylamines
ES3033433T3 (en) Method for manufacturing isoxazolinecarboxylic acid derivatives
SK14772000A3 (en) Improved process for the manufacture of n-(1-cyanoalkyl)-2-phenoxypropionamide derivatives
CN110914261B (en) Oxadiazole oxime derivatives and their applications in agriculture
NO20024046L (en) Process for the preparation of quinolone carboxylic acids and their intermediates

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A1

Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BY BZ CA CH CN CO CR CU CZ DE DK DM DZ EC EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NO NZ OM PH PL PT RO RU SD SE SG SI SK SL TJ TM TR TT TZ UA UG US UZ VN YU ZA ZW

AL Designated countries for regional patents

Kind code of ref document: A1

Designated state(s): GH GM KE LS MW MZ SD SL SZ TZ UG ZM ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE TR BF BJ CF CG CI CM GA GN GQ GW ML MR NE SN TD TG

121 Ep: the epo has been informed by wipo that ep was designated in this application
REG Reference to national code

Ref country code: DE

Ref legal event code: 8642

122 Ep: pct application non-entry in european phase
NENP Non-entry into the national phase

Ref country code: JP

WWW Wipo information: withdrawn in national office

Country of ref document: JP